WO2004037127A2 - Capsular intraocular lens implant having a refractive liquid therein - Google Patents

Capsular intraocular lens implant having a refractive liquid therein Download PDF

Info

Publication number
WO2004037127A2
WO2004037127A2 PCT/US2003/034163 US0334163W WO2004037127A2 WO 2004037127 A2 WO2004037127 A2 WO 2004037127A2 US 0334163 W US0334163 W US 0334163W WO 2004037127 A2 WO2004037127 A2 WO 2004037127A2
Authority
WO
WIPO (PCT)
Prior art keywords
lens
optic
iol
positioning member
anterior
Prior art date
Application number
PCT/US2003/034163
Other languages
French (fr)
Other versions
WO2004037127A3 (en
Inventor
Randall Woods
Robert Schulz
Original Assignee
Randall Woods
Robert Schulz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randall Woods, Robert Schulz filed Critical Randall Woods
Priority to JP2005501704A priority Critical patent/JP4473217B2/en
Priority to CA2503961A priority patent/CA2503961C/en
Priority to EP03809651A priority patent/EP1562521B1/en
Priority to DE60330492T priority patent/DE60330492D1/en
Priority to AU2003301524A priority patent/AU2003301524B8/en
Priority to AT03809651T priority patent/ATE451079T1/en
Publication of WO2004037127A2 publication Critical patent/WO2004037127A2/en
Publication of WO2004037127A3 publication Critical patent/WO2004037127A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1624Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
    • A61F2/1635Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1648Multipart lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2002/1681Intraocular lenses having supporting structure for lens, e.g. haptics
    • A61F2002/1682Intraocular lenses having supporting structure for lens, e.g. haptics having mechanical force transfer mechanism to the lens, e.g. for accommodating lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0053Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in optical properties

Definitions

  • the present invention relates to an accommodating intraocular lens implant (IOL), containing a refractive material therein, for surgical replacement of the natural crystalline lens to treat refractive errors in the human eye.
  • IOL intraocular lens implant
  • Refractive errors in the eye affect one's ability to properly focus an image upon the retina due to a change in the refractive medium of the eye, e.g., the cornea, the natural crystalline lens, or both.
  • the refractive errors pertinent to this application include myopia, hyperopia, and presbyopia.
  • a myopic lacks the ability to focus an image located at a distance from the viewer because the cornea has become elongated, thereby increasing the eye's focal length.
  • a hyperopic lacks the ability to focus on objects located near the viewer because the cornea is not elongated enough or is too flat, and cannot refract light properly upon the retina. Instead, light entering the eye does not bend sharply enough to focus upon the retina.
  • Presbyopia is another type of refractive error which results in the inability of the eye to focus because of hardening of the natural crystalline lens.
  • the hardened natural crystalline lens prevents focusing upon obj ects located near to the viewer. Presbyopia occurs in conjunction with myopia or hyperopia.
  • the known treatment varies with the type of refractive error to be corrected.
  • Each of the refractive errors maybe corrected by external spectacle lenses.
  • refractive surgery is known in the art for correcting the aforementioned refractive errors, and includes radial keratotomy, astigmatic keratotomy, photoreflective keratectomy, and laser in situ keratomileusis (LASIK).
  • LASIK laser in situ keratomileusis
  • Each of the refractive surgical methods mentioned above involve making multiple incisions into the cornea in order to reshape it.
  • Possible side effects of refractive surgery include irregular astigmatism, infection, or haze formation which could result in permanent changes in the cornea and possible loss of best-corrected visual acuity.
  • a possibility of under or over correction also exists with the aforementioned refractive surgeries.
  • none of these refractive surgeries can be used to correct all of the above-referenced refractive errors.
  • IOLs have been used to treat cataracts.
  • the first implant of an IOL within the eye to treat cataracts occurred in 1949.
  • This experimental surgery attempted to place the replacement lens in the posterior chamber of the eye behind the iris.
  • Problems such as dislocation after implantation forced abandonment of this approach, and for some period thereafter IOLs were implanted in the anterior chamber of the eye.
  • IOLs implanted in the posterior chamber are disclosed in U.S. Patent Nos. 3,718,870, 3,866,249, 3,913,148, 3,925,825, 4,014,049, 4,041,552, 4,053,953, and 4,285,072. None of these IOLs have accommodation capability.
  • U.S. Patent No. 4,254,509 to Tennant discloses an IOL which moves in an anterior direction upon contraction of the ciliary body and which is located anterior to the iris. Although the Tennant IOL claims to possess accommodation capabilities, it presents the same disadvantages as other anterior chamber lenses.
  • U.S. Patent No.4,253,199 to Banko approaches the problem of providing a focusable IOL in a different manner, by providing a replacement IOL of deformable material sutured to the ciliary body. This IOL functions in much the same manner as the natural crystalline lens, but may cause bleeding because it requires sutures.
  • This IOL is located in the posterior area of the capsule and is biased toward the fovea or rear of the eye.
  • the Levy IOL is deficient because it requires the ciliary muscle to exert force through the zonules on the capsule in order to compress the haptics inward and drive the optic forward for near vision.
  • the ciliary muscles do not exert any force during contraction because the zonules, being flexible filaments, exert only tension, not compression on the capsule.
  • the natural elasticity of the IOL causes the capsule to become more spherical upon contraction of the ciliary muscle.
  • U.S. Patent No. 5,674,282 to Cumming is directed towards an allegedly accommodating IOL for implanting within the capsule of an eye.
  • the Cumming IOL comprises a central optic and two plate haptics which extend radially outward from diametrically opposite sides of the optic and are movable anteriorly and posteriorly relative to the optic.
  • the Cumming IOL suffers from the same shortcomings as the Levy IOL in that the haptics are biased anteriorly by pressure from the ciliary bodies. This will eventually lead to pressure necrosis of the ciliary body.
  • U.S. Patent No. 4,842,601 to Smith discloses an allegedly accommodating IOL having anterior and posterior members which urge against the anterior and posterior walls of the capsule.
  • the muscular action exerted on the capsule will cause the IOL to flatten, thereby changing the focus thereof.
  • the Smith IOL is formed of first and second plastic lens members connected to one another adjacent their peripheral edges so as to provide a cavity therebetween. The connection between the lens members is accomplished by way of a U-shaped flange on the first member which forms an inwardly facing groove for receiving an outwardly extended flange on the second member.
  • the Smith IOL is faulty because the structure of the lens members makes surgical implantation thereof extremely difficult to accomplish, even for highly skilled surgeons. Furthermore, the Smith IOL requires sutures which increases the risk of bleeding.
  • the IOLs discussed above replaced the opaque crystalline lens symptomatic of cataracts through a small incision in the iris and anterior wall of the biological capsule.
  • the IOLs for the treatment of cataracts differed from the present invention in that the present invention utilizes a highly refractive material to compensate for defects in the eye's natural refractive media, e.g, the cornea and the natural crystalline lens.
  • a lightweight IOL which can be used to correct a variety of refractive errors in conjunction with other eye defects which require replacement of the natural crystalline lens, such as cataracts.
  • This IOL should be readily insertable into the capsule and should last for a substantial number of years without damaging any of the eye components.
  • the IOL of the present invention addresses this need because it provides a lightweight accommodating IOL, containing a highly refractive material therein, which is safe for long term use in an eye.
  • the present invention presents a significant advance in the art because it provides an IOL for the safe and effective treatment of refractive errors in combination with other defects such as cataracts.
  • the IOL comprises a resilient optic formed of a highly refractive material operably coupled to a flexible optic positioning member to change shape in response to ciliary body movement, i.e., contraction and retraction of the ciliary body.
  • ciliary body movement i.e., contraction and retraction of the ciliary body.
  • the IOL becomes discoid in shape and allows the viewer to focus upon objects located at a distant therefrom.
  • the ciliary body contracts, it becomes thicker and causes the zonules to ease the tensional pull.
  • the IOL becomes spheroid in shape and allows the viewer to focus upon objects located near to the viewer.
  • the optic is formed of refractive material that has an index of refraction of from about 1.36 to 1.5 or higher (e.g., hydrocarbon oil, silicone oil, or silicone gel).
  • refractive material that has an index of refraction of from about 1.36 to 1.5 or higher (e.g., hydrocarbon oil, silicone oil, or silicone gel).
  • a pre-formed capsule having a thin, continuous wall wherein the refractive material is enveloped.
  • the optic maybe coupled with various optic positioning members commonly used in IOL construction depending upon the user's eyesight.
  • the optic maybe positioned within the capsule of the eye such that the anterior surface of the optic faces either the anterior or the posterior portion of the eye.
  • the optic will vault posteriorly in response to contraction of the ciliary body.
  • the change in the radius of curvature of the optic will counteract the effects of the negative accommodation, i.e., movement of the optic posteriorly.
  • the resiliency of the optic permits a small change in radius of curvature which, when coupled with the relatively high index of refraction of the refractive material, results in an optic having greater light-bending properties than conventional optics.
  • Another preferred embodiment presents a resilient optic and a posterior rigid optic both operably coupled on opposed sides of an optic positioning member to change shape in response to ciliary body movement.
  • the optics are positioned on opposite segments of the optic positioning members such that they share the same focal point.
  • a similar embodiment transposes the structure described immediately above by implanting the IOL within the eye such that the rigid optic is the anterior optic and the resilient optic is the posterior optic.
  • Another embodiment of the present invention presents two optics positioned on the same segment of the optic positioning member wherein a rigid optic surrounds a resilient optic.
  • the resilient optic changes shape in response to ciliary body movement while the rigid optic essentially retains its shape.
  • Yet another preferred embodiment of the IOL of the present invention includes an optic positioning member comprised of an enclosed flexible bag having resilient fill material therein.
  • the enclosed flexible bag presents an anterior segment and an opposed posterior segment, each having an optic.
  • the optic positioning member is pre-formed to present opposed optic surfaces, hence, the optics are integral with the optic positioning member.
  • the resilient fill material is comprised of the same refractive material used in the above-referenced resilient optic construction. This embodiment also functions similarly to the IOLs discussed above because the anterior optic surface moves anteriorly and the posterior optic surface moves posteriorly in response to contraction of the ciliary body.
  • the optic surfaces of the flexible bag optic positioning member present a small change in the radius of curvature (e.g., 5 - 4.6 mm) from the accommodated to disaccommodated shapes, coupled with high refractive power thereby permitting retinal receipt of an observed image.
  • Another embodiment of the present invention is similar to the embodiments having opposed optics, described above, except that the optic positioning member of this embodiment does not completely house the refractive material.
  • the refractive material of this IOL protrudes outward to extend beyond the outer margins of the anterior segment through an opening in the optic positioning member to define a resilient optic.
  • the posterior segment of the optic positioning member supports a second posterior rigid optic positioned in opposition to the resilient optic.
  • the rigid optic is constructed of the same material as the optic positioning member.
  • the resilient material is captively retained by the segments of the optic positioning member, but also directly contacts the biological capsule. Contraction of the ciliary body transfers sufficient force to the resilient and protuberant refractive material which in turn defines an optic operable to change shape in response to ciliary body movement.
  • This embodiment may be constructed without the addition of a second opposed rigid optic depending upon identifiable surgical needs.
  • FIG. 1 is a vertical sectional view showing an IOL of the invention within the capsule of an eye, with the eye focused on an object distant from the viewer;
  • Fig. 2 is a vertical sectional view of a preferred IOL of the invention
  • Fig. 3 is an anterior perspective view of the IOL of Figs. 1 and 2
  • Fig. 4 illustrates another embodiment of the invention
  • Fig. 5 illustrates another embodiment of the invention
  • Fig. 6 illustrates another embodiment of the invention
  • Fig. 7 is a vertical sectional view of the IOL of Fig. 3 showing the optic bonded to the anterior surface of the anterior segment of the IOL of the present invention
  • Fig. 8 is a vertical sectional view of the IOL of Fig. 3 showing the optic bonded to the posterior surface of the anterior segment of the IOL of the invention
  • Fig. 9 is a vertical sectional view of another embodiment of the invention showing the optic located at the anterior segment of the IOL and a posterior rigid optic at the posterior segment of the IOL;
  • Fig. 10 is a vertical sectional view of the IOL of Fig.9 positioned within the eye, with the optic located at the posterior segment of the IOL and a rigid optic at the anterior segment;
  • Fig. 11 is a vertical sectional view of a preferred IOL of the invention within the capsule of an eye, with the eye focused on an object distant from the viewer;
  • Fig. 12 is a view similar to that of Fig. 11, but illustrating the IOL in an accommodated position owing to contraction of the ciliary body;
  • Fig. 13 is a plan view of a preferred IOL of the invention
  • Fig. 14 is a vertical sectional view taken along line 14-14 of Fig. 13
  • Fig. 15 is a greatly enlarged fragmentary of the IOL of Figs. 11-14;
  • Fig. 16 is a vertical sectional view similar to that of Figs. 7-10, but illustrating the optic constructed without an enveloping capsule;
  • Fig. 17 is a vertical sectional view of another embodiment of the present invention, illustrating a resilient optic sunounded by a rigid optic;
  • Fig. 18 is a vertical sectional view of another embodiment of the present invention, showing an IOL of the invention within the capsule of an eye, with the eye focused on an object located at a distance from the viewer;
  • Fig.19 is a view similar to that of Fig. 18, but illustrating the IOL in an accommodated position owing to contraction of the ciliary muscle;
  • Fig. 20 is a vertical sectional view showing an IOL of the invention within the capsule of an eye, with the optic positioned posteriorly;
  • Fig. 21 is a view similar to that of Fig.20, but illustrating the IOL in a disaccommodated position owing to retraction of the ciliary muscle;
  • Fig. 22 is a vertical sectional view of another embodiment of the IOL of the present invention positioned within the capsule of the eye;
  • Fig. 23 is a vertical sectional view of another IOL of the invention where the IOL is positioned in the capsule of an eye, with the eye focused on an object distant from the viewer;
  • Fig. 24 is a view similar to that of Fig. 23, but illustrating the IOL in an accommodated position owing to contraction of the ciliary body;
  • Fig. 25 is a plan view of the IOL of Figs. 23-24.
  • Fig. 26 is a vertical sectional view taken along line 26-26 of Fig. 25.
  • the present invention is in the form of an IOL for surgical replacement of the natural crystalline lens in the treatment of refractive error in the human eye.
  • Fig.1 shows the various components of the human eye 10 pertinent to this invention.
  • the eye 10 includes an anterior portion 12 and a posterior portion 14.
  • the anterior portion 12 of the eye 10 is covered by a cornea 16 which encloses and forms an anterior chamber 18.
  • the anterior chamber 18 contains aqueous fluid and is bounded at the rear by an iris 20.
  • the iris 20 opens and closes to admit appropriate quantities of light into the inner portions of the eye 10.
  • the eye 10 also includes a capsule 22 which ordinarily contains the natural crystalline lens (which would be located at numeral 24 in the natural, unmodified eye).
  • the eye 10 includes a ciliary muscle or body 26 having zonular fibers 28 (also referred to as zonules) which are attached to the eye 10.
  • the vitreous humor 30 is located posterior to the capsule 22 and anterior to the retina (not pictured).
  • the vitreous humor 30 contains vitreous fluid.
  • the cornea 16 has an index of refraction of 1.37, and is largely responsible for refracting light into the eye 10.
  • the light then slightly diverges in the fluid- filled anterior chamber 18 which has an index of refraction close to that of water, e.g., approximately 1.33, and travels to the natural crystalline lens 24.
  • the natural crystalline lens 24 is a biconvex structure having an index of refraction of 1.4 at its center and an index of refraction of 1.38 at its outer portion.
  • the natural crystalline lens 24 is responsible for refracting much of the light entering the human eye 10.
  • the anterior portion of the natural crystalline lens 24 converges light onto its posterior portion where light is then diverged.
  • the image being viewed is inverted.
  • the inverted image (or light) then travels into the vitreous humor 30 and tluough the vitreous fluid.
  • the vitreous fluid has an index of refraction close to that of water, e.g. 1.33.
  • the retina is responsible for relaying electric signals to the optic nerve.
  • the optic nerve then carries the message to the brain which translates the inverted image into its upright position. Ocular adjustments for sharp focusing of objects viewed at different distances are accomplished by the action of the ciliary body 26 on the capsule 22 and natural crystalline lens 24 through the zonules 28.
  • the ciliary body 26 contracts, allowing the capsule 22 to return to a more spherical shape for viewing obj ects near to the viewer.
  • the ciliary body 26 retracts, the ciliary body 26 pulls on the zonules 28 to make the capsule 22 more discoid thus permitting objects at a distance to be viewed in proper focus.
  • Fig. 1 To summarize, when the eye 10 focuses, the capsule 22 changes shape to appropriately distribute the light admitted through the cornea 16 and the iris 20.
  • an IOL in accordance with the invention comprises an optic 32 operably coupled to an optic positioning member and implanted within the capsule 22 of the human eye 10.
  • the IOL changes shape in response to ciliary body 26 movement.
  • the optic 32 of the present invention is formed of a highly refractive material.
  • the refractive material has an index of refraction of from about 1.36 to 1.5 or higher.
  • preferred refractive materials include silicone oil, hydrocarbon oil, and more preferably silicone gel (available from Nusil Technology).
  • the refractive material used is a gel, the gel may be pre-formed into the desired optic shape and adhered onto the optic positioning member without encapsulating it.
  • the optic 32 may be utilized in a number of ways in a variety of optic positioning members.
  • the optic positioning members discussed herein are preferably formed of any appropriate biologically inert material conventionally used in IOL construction (e.g., elastic, synthetic resin materials).
  • suitable materials include acrylates (such as polymethylmethacrylates), silicones, and mixtures of acrylates and silicones. It is contemplated that mixtures of silicones and acrylates comprise both chemical mixtures, such as silicone-acrylate blends, and various combinations of silicones and acrylates employed to construct the lens.
  • the optic positioning members according to the invention be constructed of a material having an elastic memory (i.e., the material should be capable of substantially recovering its original size and shape after a deforming force has been removed).
  • An example of a preferred material having elastic memory is MEMORYLENS (available from Mentor Ophthalmics in California).
  • the preferred embodiments of the IOL of the instant invention discussed immediately below demonstrate the variety of optic positioning members that maybe operably coupled with the inventive optic to correct refractive enors in the eye.
  • the terms rigid optic and resilient optic are used herein as relative terms to one another.
  • a rigid optic may be any optic that is less resilient than the resilient optic of the present invention, even though the rigid optic may be more resilient than another rigid optic.
  • the optics of the present invention may be made of varying degrees of resiliency and rigidity depending upon the materials used, therefore, the terms rigid and resilient should not be used as limiting terms other than to convey a specific relationship between two optics within the scope of this invention.
  • the optic 32 presents a convex anterior surface 36 and a planar posterior surface 38 (hereinafter plano-convex). Although the optic 32 is illustrated as plano-convex, the size and shape of the optic 32 maybe varied depending upon the user's eyesight.
  • the optic 32 is composed of a refractive material 40 that is enveloped within a pre-formed capsule 42 formed of a thin continuous wall 43 made of the same flexible synthetic resin material as the optic positioning member 34.
  • the thin wall 43 has an anterior section 33 facing the anterior portion 12 of the eye 10 and a posterior section 41 facing the posterior portion 14 of the eye 10 respectively. (See Fig.
  • the anterior section 33 of the thin wall 43 has a thickness of from about 0.0005 to 0.025 mm, and more preferably of about 0.004 mm, when the material used is silicone.
  • the posterior section 41 of the thin wall 43 has a thickness of from about 0.0005 to 0.025 mm, and more preferably of about 0.003 mm, when the material used is silicone.
  • the anterior section 33 and the posterior section 41 of the thin wall 43 may also be constructed of uniform thickness.
  • the optic 32 may also be constructed without the refractive material housed within the pre-formed capsule 42 when the refractive material used is the silicone gel material discussed above. (See Fig. 16)
  • the optic positioning member 34 may be integral with optic 32 or may be structurally distinct. As illustrated, the optic positioning member 34 comprises a main body 35 which includes an annular posterior segment 44 with a central opening 46 and an anterior segment 37. Anterior segment 37 and posterior segment 44 are located on either side of equatorial axis 56. A plurality of circumferentially spaced, arcuate in cross-section positioning legs 48 extend from the segment 44 and are joined to the margin of optic 32, with openings 50 defined between adjacent pairs of the legs 48. As perhaps best seen in Fig. 2, the legs 48 cooperatively present, with the optic 32, a substantially discoid shape with a central chamber 52.
  • the legs 48 also define an annular equatorial segment 54 disposed on opposite sides of equatorial axis 56. (See Fig. 2)
  • the overall IOL 61 further presents a central polar axis 58 as shown.
  • the outside dimension of the IOL 61 at the equatorial segment 48 is from about 8 to 12 mm.
  • the outside dimension along polar axis 58 is typically from about 1 to 5 mm.
  • the dimensions of the IOLs of the present invention must conform to the size and shape of the eye to be fitted.
  • the optic positioning member 34 discussed herein is configured so as to substantially conform with the capsule 22, particularly to the equatorial portion 27 of the capsule 22. This is shown in Figs. 1 and 2 where it will be observed that the equatorial segment 54 of the IOL 61 is in substantially conforming contact with the inner surface of the equatorial portion 27 of capsule 22. This close conforming relationship is maintained notwithstanding the extent of accommodation of IOL 61.
  • IOL 61 is inserted into the human eye 10 in the following manner.
  • IOL 61 is then folded into a compact size for insertion in the capsule 22 through opening 21.
  • the capsule 22 is filled with fluids (e.g., saline solution) which enter the IOL 61 causing IOL 61 to return to its original, non-deformed state as shown in Fig. 1.
  • fluids e.g., saline solution
  • IOL 61 may be provided with a very thin membrane (not shown) in covering relationship as disclosed inU.S. Patent Application S/N 09/940,018, filed August 27, 2001 , which is incorporated by reference herein. It is contemplated that the membrane would be formed of the same synthetic resin as the optic positioning member 34 but would be much thinner (on the order of a few thousandths of an inch) than the remainder of the optic positioning member 34. The purpose of the membrane is to prevent or at least impede the passage of migratory cells through openings within the IOL 61 and into the inner chamber of the IOL 61. Furthermore, optic positioning member 34 construction is disclosed in previously filed application for U.S. Letters Patent Serial No. entitled Accommodating Intraocular Lens
  • Implantation of the inventive IOL 61 restores normal vision by providing an optic 32 formed of highly refractive material capable of bending light onto the retina. After implantation of the IOL 61 in the human eye 10, light refracts at the air-cornea interface in the same manner as the natural human eye 10. The light travels through the fluid-filled anterior chamber 18 and onto the optic 32. The radius of curvature of the optic 32 changes in response to ciliary body 26 movement, thus affecting the optic's 32 refractive capabilities.
  • the IOL 61 projects an observed image onto the retina, but it also accommodates in response to action of the ciliary body 26 in connection with the zonules 28 to view objects located both near and far from the viewer.
  • the sensory cells within the retina signal the ciliary body 26 to relax, thus pulling on the zonules 28 to make the capsule 22 more discoid as shown in Fig. 1.
  • the polar dimension of the capsule 22 nanows, subsequently causing the polar dimension of the IOL 61 to similarly nanow.
  • the optic positioning member 34 is operably coupled with the optic 32 of the present invention to change shape in response to ciliary body 26 movement, hi this regard, the movement of the ciliary body 26 causes the optic 32 to move posteriorly and anteriorly, respectively. Contraction of the ciliary body 26 and subsequent relaxation of the zonules 28 will cause the optic 32 to vault anteriorly.
  • the IOL 61 of the present invention typically has a diopter value of from about 16 to 26.
  • the diopter value of a lens is defined as the reciprocal of the focal length in meters:
  • Diopter 1/focal length (m).
  • Focal length is the distance from the center of the lens to the object being viewed.
  • the focal length must decrease as magnification increases.
  • the diopter value expresses the refractive capacity of a lens which is associated with the radius of curvature of the optics. Generally, an increased diopter value indicates that the optic is thicker and also has a lesser radius of curvature thus possessing greater light-bending capability.
  • the IOL 60 is similar to IOL 61 illustrated in Figs. 1-3.
  • IOL 60 comprises an optic positioning member 62 wherein the optic positioning member 62 presents an anterior segment 66 and a posterior segment 68 each having a central opening therein 67, 69.
  • a plurality of individually continuous, circumferentially spaced, arcuate in cross-section positioning legs 64 extend from anterior segment 66 and are joined to the margin of optic 32, with openings 71 defined between adjacent pairs of the legs 64, by haptic arms 72.
  • the haptic arms 72 extend between the posterior segment 68 to the margin of the optic 32.
  • the haptic arms 72 join the optic 32 and the optic positioning member 62.
  • This embodiment is similar to IOL 61 in that it may also be constructed with a thin membrane as disclosed in U.S. Patent Application S/N 09/940,018, filed August 27, 2001 which has been incorporated by reference herein.
  • IOL 60 is implanted and operates in the same manner as IOL 61.
  • the IOL 60 of the present invention typically has a diopter value of from about 16 to 26.
  • Furthemiore, optic positioning member 62 construction is disclosed in previously filed application for U.S . Letters Patent Serial No. entitled Accommodating Intraocular Lens
  • FIG. 60a A preferred IOL 60a according to the invention is illustrated in Fig 5. Similar to the IOL 60 embodiment described above, this IOL 60a comprises an optic 32 and an optic positioning member 74 presenting an anterior segment 66a and a posterior segment 68a. A plurality of circumferentially spaced, arcuate in cross-section positioning legs 76 extend from the anterior segment 66a to the optic 32. The haptic arm 72a extends posteriorly from the anterior segment 66a to the optic 32.
  • the optic 32 maybe connected to the optic positioning member 74 via a plurality of haptic arms (not shown). The plurality of haptic arms are disposed at various locations about anterior segment 66a and extend posteriorly towards the optic 32.
  • the plurality of legs 76 are continuously attached to each other through continuous sections 80 presenting annular orifices 82 therethrough.
  • This embodiment is similar to IOL 61 and 60 in that it may also be constructed with a thin membrane as disclosed in U.S. Patent Application S/N 09/940,018, filed August 27, 2001 which has been incorporated by reference herein.
  • IOL 60a is implanted and operates in a similar manner to IOLs 61 and 60.
  • the IOL 60a of the present invention typically has a diopter value of from about 16 to 26.
  • optic positioning member 74 is disclosed in previously filed application for U.S. Letters Patent Serial No. entitled Accommodating Intraocular Lens Implant and U.S.
  • FIG. 6 depicts yet another preferred IOL 60b according to the invention.
  • This IOL 60b also comprises an optic 32 and an optic positioning member 84 presenting an anterior segment 66b and a posterior segment 68b.
  • the optic positioning member 84 further comprises a plurality of circumferentially spaced, arcuate in cross-section positioning legs 88 having openings 86 therein between adjacent pairs of legs 88.
  • the IOL 60b is configured in much the same fashion as the IOL 60, with the exception that a plurality of haptic arms 72b extend from equatorial segment 54 toward the optic 32.
  • the haptic arms 72b are vaulted slightly toward anterior segment 66b.
  • This embodiment is similar to IOL 61, 60, and 60a in that it may also be constructed with a thin membrane as disclosed in U.S. Patent Application S/N 09/940,018, filed August 27, 2001 which has been incorporated by reference herein.
  • IOL 60b is implanted and operates in a similar manner to IOLs 61 , 60 and 60a.
  • the IOL 60b of the present invention typically has a diopter value of from about 16 to 26.
  • optic positioning member 84 is disclosed in previously filed application for
  • IOL 61d is another embodiment of the present invention.
  • IOL 61d presents a variation upon the structure of IOL 61 wherein the optic 32 is bound to either the anterior surface 31(a) or the posterior surface 31(b) of the optic positioning member 34.
  • IOL 61d operates in and is implanted in the same manner as IOL 61.
  • IOL 61d illustrated in Figs. 7 and 8 comprises a liquid refractive material 40 enveloped within the capsule 42.
  • the indices of refraction of the wall 43 and the refractive material 40 may be varied to satiate surgical, medical, or manufacturing needs.
  • IOL 61a differs from the embodiments discussed thus far in that while the optic 32 is operably coupled to the anterior segment 37 of the optic positioning member, a second rigid optic 90 is operably coupled to the posterior segment 44.
  • the optics 32, 90 are positioned on opposed segments 37, 44 of the optic positioning member such that the optics 32, 90 share the same optical axis. Opposition or opposed in this context is used consistently in this application to mean positioned on the opposite side of equatorial axis 56(a) such that both optics share substantially the same optic axis, and are aligned such that the IOL provides undistorted vision.
  • the posterior optic 90 is made of the same material as the optic positioning member 34, however, one of ordinary skill in the art will recognize that the posterior optic 90 may be constructed of the inventive refractive material as well.
  • This embodiment is implanted and operates in essentially the same manner as the IOLs discussed thus far, but differs because it includes a second opposed rigid optic 90.
  • the anterior optic 32 converges light upon the posterior optic 90.
  • the posterior optic 90 diverges the light onto the retina. Any irregularities in the cornea 16 or the natural crystalline lens 24 are counteracted by the highly refractive material 102, thereby bringing the image to focus upon the retina.
  • This embodiment also accommodates in response to ciliary body 26 movement. When the ciliary body 26 contracts, the IOL 61a assumes a spheroid shape.
  • the anterior optic 32 moves anteriorly whereas the posterior optic 90 moves posteriorly.
  • the IOL 61a of the present invention typically has a diopter value of from about 16 to 26.
  • IOL 61a may also be positioned within the eye 10 such that the rigid optic 90 is located anteriorly and the optic 32 is positioned posteriorly as illustrated in Figure 10. When the IOL 61a is positioned within the eye 10 in this manner, the IOL 61 has a combined total refraction of about 16 to 26 diopters.
  • IOL 92 presents a unitary structure for implantation within the capsule 22 of the human eye 10.
  • IOL 92 comprises a main body presenting a pre-formed enclosed flexible bag 100 having a resilient fill material 102(a) therein.
  • the pre-formed enclosed flexible bag 100 may also be filled with other refractive media disclosed herein.
  • Flexible bag 100 comprises an anterior segment 104, and a posterior segment 106.
  • Flexible bag further includes wall 112 which, when viewed in cross section, forms and extends radially from an anterior arcuate wall segment 94 and converges upon the posterior segment 106 of the IOL 92 to form an opposing posterior arcuate wall segment 96.
  • the opposing arcuate wall segments 94, 96 define opposed anterior and posterior optic surfaces 94a, 96a when cavity 114 of enclosed flexible bag 100 is filled with material 102(a).
  • optic may be used interchangeably to describe optic surfaces 94a, 96a within the remainder of this disclosure.
  • the anterior optic surface 94a and the posterior optic surface 96a have a combined radius of curvature of from about 16 to 26 diopters. (See Fig. 11)
  • the anterior optic surface 94a and the posterior optic surface 96a are both illustrated as convex in shape. When viewed in cross- section, anterior segment 94 and posterior segment 96 are connected by a pair of opposed arcuate equatorial segments 124a as shown in Fig. 14.
  • Wall 112 includes a fill aperture 118 with a plug therein closing the aperture 118.
  • aperture 118 is illustrated at location 120 of the IOL 92, the aperture 118 can be formed at any location on the IOL 92.
  • the IOL 92 will have an outer equatorial diameter (distance of IOL 92 taken through equatorial axis 124) of from about 8 to 12 mm. (See Fig. 13)
  • the IOL will have an outside dimension through the central polar axis 122 of from about 2 to 5 mm. (See Fig. 13)
  • An ophthalmologist fills cavity 114 with material 102(a) prior to surgical implantation of the IOL 92 within the human eye 10 by inserting the material 102(a) through the aperture 118. After cavity 114 is filled, the aperture 118 is sealed. The ophthalmologist removes the natural crystalline lens 24 by conventional methods, leaving an opening in the anterior wall 23(a) of the capsule 22. The IOL 92 is folded an inserted within the capsule 22 through the opening. Implantation of the IOL 92 does not require suturing of the eye 10 be because the instant IOL 92 is capable of being implanted through a small opening in the capsule 22.
  • IOL 92 operates in the same manner as IOL 61 a because IOL 92 includes opposed optic surfaces 94, 96. Anterior optic 94 converges light upon the posterior optic 96, which in turn, diverges light onto the retina. The IOL 92 responds to contraction of the ciliary body 26 by assuming a spheroid shape.
  • IOL ofFig l6 [IOL 61]
  • Fig. 16 illustrates optic 32 of the inventive IOL 61 formed from a resilient silicone gel material. Therefore, the IOL 61 of Fig. 16 does not depict the refractive material enveloped within a pre-formed capsule 42 having a thin continuous wall 43. The capsule 42 is not needed when the refractive material is fonned from a resilient, shape-retaining synthetic material such as the silicone gel discussed above.
  • Another prefened embodiment of the present invention includes an optic positioning member 34 operably coupled with two optics 142, 144 to change shape in response to ciliary body
  • IOL 61c includes a resilient optic 142 sunounded by a rigid optic 144.
  • the resilient optic 142 is fomied of the refractive material discussed above.
  • the rigid optic 144 is formed of the same material as the optic positioning member 34. Both optics 142, 144 are housed within a pre-formed capsule 42 as described in connection with IOL 61.
  • IOL 61c operates in a similar manner as the embodiments discussed so far, but differs in that the resilient optic 142 sunounded by the rigid optic 144 maintains a constant volume in response to ciliary body 26 movement.
  • IOL of Figs. 18 and 19 Another prefened embodiment is an IOL 200 having an annular optic positioning member
  • the IOL 200 further includes an anterior resilient optic 216 and a posterior rigid optic 218 operably coupled to the optic positioning member 210 to change shape in response to ciliary body 26 movement.
  • the anterior segment 212 of the optic positioning member 210 contains an opening 220 of from about 7 to 3 mm , and more preferably of about 4 mm wide.
  • the anterior segment 212 further includes an outer margin 222 and an inner margin 224.
  • the outer margin 222 is defined as the anterior portion of the anterior segment 212, or that portion of the segment 212 closest to the iris 20.
  • the posterior segment 214 also includes an inner margin 226 and an outer margin 228 wherein the inner margin 226 of the posterior segment 214 is the margin closest to the iris 20 as well.
  • the space between the anterior segment 212 and the posterior segment 214 is occupied by refractive material such that the refractive material is adj acent to the inner margins 224, 226 of the segments 212, 214.
  • the refractive material protrudes beyond the outer margin 222 of the anterior segment 212. This protrusion defines the resilient optic 216.
  • the refractive material used herein is the refractive silicone gel discussed above.
  • the silicone gel refractive material maybe pre-formed into the desired shape and connected, by posts, to the segments 212, 214 of the optic positioning member 210.
  • the refractive material may also be encompassed within a bladder which is also similarly connected to the segments 212, 214. In this case, the refractive material used may also be a liquid.
  • the IOL 200 may further include a second rigid optic 218 opposed to resilient optic 216.
  • the rigid optic 218 is made of the same material as the optic positioning member 210 and is supported by the posterior segment 214. As mentioned above, the space between the segments 212, 214 is occupied by refractive material.
  • This IOL 200 differs from the other embodiments discussed herein because the refractive material is not completely contained by the optic positioning member 210 in addition to the optic 216 defining protrusion which extends beyond the outer margin 222 of the anterior segment 212.
  • the refractive material is positioned between the two segments 212, 214 such that the refractive material comes into direct contact with the biological capsule 22 at locations 230.
  • IOL 200 is implanted in the same manner as IOL 61 after IOL 200 is assembled, and operates in a similar manner to the other IOLs having opposed optics discussed herein.
  • Contraction of the ciliary body 26 and subsequent relaxation of the zonules 28 exerts force upon the refractive material causing the material to protrude outward to extend beyond the outer margin 222 of the anterior segment 212.
  • the zonules 28 exert a tensional pull upon the capsule 22, and the refractive material assumes its more flattened shape to view objects located at a distance.
  • FIG. 20 illustrates the IOL of the present invention in the accommodated shape.
  • Fig. 21 illustrates the IOL in the disaccommodated shape.
  • IOL 61 e illustrated in Fig. 22 is similar to IOL 61c illustrated in Fig. 17. IOL 61 e differs from IOL 61c in that the resilient optic 142a sunounds the rigid optic 144a. Fig. 22 illustrates IOL 61 e positioned posteriorly in the capsule 22 of the eye 10. The resilient optic 142a changes shape in response to ciliary body 26 movement. The change in curvature of the resilient optic 142a provides about 3 diopters of convergence while the rigid optic 144a essentially maintains its shape.
  • FIGS 23-26 depict yet another IOL 146 according to the invention.
  • IOL 146 includes an optic 148 and an optic positioning element 150.
  • Optic positioning element 150 comprises a plurality of circumferentially spaced-apart, haptic arms 152.
  • a plurality of circumferentially spaced-apart, arcuate in cross-section, positioning legs 154 are joined with the optic via arms 152 at bight 156, thus causingthe arms 152 and optic 148 to lie substantially within the plane created by the equator of the lens.
  • the legs 154 extend both anteriorly and posteriorly in a curved fashion to form respective anterior segments 155 and posterior segments 157 which are joined on either side of the IOL 146 by annular portions 158 and 160.
  • annular portion 158 is located anterior to the optic 148 while annular portion 160 is located posterior to the optic 148.
  • the IOL 146 illustrated also includes optional openings 162 which can be included to assist with positioning of the IOL 146 within the capsule or to allow fluid communication on either side of the optic 148.
  • This embodiment is similar to IOL 60 and 61 in that it may also be constructed with a thin membrane between legs 154 as disclosed in U.S. Patent Application S/N 09/940,018, filed August 27, 2001, which has been incorporated by reference herein. Also, rather than being joined by annular portions 158, 160, the legs 154 couldbe freestanding such as is shown in the embodiment of Fig. 4. The legs could be joined only on the anterior side of IOL 146, only on the posterior side of IOL 146, or not joined to one another on either side of IOL 146. Also, while optic 148 is plano-convex in shape, other shapes of optics could be utilized as well. In use, the IOL 146 is implanted as discussed with respect to the previous embodiments.
  • the IOL 146 achieves accommodation by the same mechanism of the lenses discussed above. That is, because the optic 148 is formed of a flexible, resilient material, and the arms 152 and legs 154 are formed of a material which is stiffer or less resilient than that of the optic 148, when the ciliary body 26 contracts, the zonules 28 relax and allow the IOL 146 to become more spheroid in shape. This causes the arms 152 to move towards the optic 148 which, in turn, causes the diameter of the optic 148 to decrease while increasing the thickness of the optic 148 as shown in Fig. 24. Thus, accommodation is achieved.
  • the IOL may be used in any situation where the natural crystalline lens 24 should be replaced.
  • the IOL may be used to conect myopia, hyperopia, presbyopia, cataracts, or a combination thereof.
  • Various refractive media may be used to fill cavity 114 of IOL depending upon the desired index of refraction.
  • the optics of each embodiment could be formed of a wide range of flexible, refractive materials. These include gels, silicone, silicone blends, refractive liquids, elastomeric materials, rubbers, acrylates, and mixtures of the foregoing, so long as the material is flexible and resilient.

Abstract

An intraocular lens having a light-transmitting optic (32, 94a, 94b, 142, 216) comprised of a synthetic light-refractive material (40, 102) operably coupled with a flexible optic positioning member (34, 62, 74, 84, 100, 210) to refract light onto the retina in order to correct refractive errors in the eye (10). The refractive material has an index of refraction of from about 1.36 to 1.5 or higher. The optic positioning member (34, 62, 74, 84, 100, 210) is constructed of a flexible synthetic resin material such as polymethylmethacrylate and permits focusing upon objects located near to and far from the viewer. The optic (32, 94a, 94b, 142, 216) of the present invention possess greater refractive capability than optics conventionally used in IOL construction, and permits retinal receipt of the image being viewed in order to correct refractive errors.

Description

CAPSULAR INTRAOCULAR LENS IMPLANT HAVING A REFRACTIVE LIQUID THEREIN
BACKGROUND OF THE INVENTION
Related Applications
This application is a continuation-in-part application of U.S. Patent Application No. 10/280,918, filed on October 25, 2002, incorporated herein by reference.
Field of the Invention
The present invention relates to an accommodating intraocular lens implant (IOL), containing a refractive material therein, for surgical replacement of the natural crystalline lens to treat refractive errors in the human eye.
Description of the Prior Art
Refractive errors in the eye affect one's ability to properly focus an image upon the retina due to a change in the refractive medium of the eye, e.g., the cornea, the natural crystalline lens, or both. The refractive errors pertinent to this application include myopia, hyperopia, and presbyopia. A myopic lacks the ability to focus an image located at a distance from the viewer because the cornea has become elongated, thereby increasing the eye's focal length. A hyperopic lacks the ability to focus on objects located near the viewer because the cornea is not elongated enough or is too flat, and cannot refract light properly upon the retina. Instead, light entering the eye does not bend sharply enough to focus upon the retina. In contrast to myopia wherein the image is brought to focus in front of the retina, hyperopia causes the image to focus behind the retina. Presbyopia is another type of refractive error which results in the inability of the eye to focus because of hardening of the natural crystalline lens. The hardened natural crystalline lens prevents focusing upon obj ects located near to the viewer. Presbyopia occurs in conjunction with myopia or hyperopia.
The known treatment varies with the type of refractive error to be corrected. Each of the refractive errors maybe corrected by external spectacle lenses. Also, refractive surgery is known in the art for correcting the aforementioned refractive errors, and includes radial keratotomy, astigmatic keratotomy, photoreflective keratectomy, and laser in situ keratomileusis (LASIK). Each of the refractive surgical methods mentioned above involve making multiple incisions into the cornea in order to reshape it. Possible side effects of refractive surgery include irregular astigmatism, infection, or haze formation which could result in permanent changes in the cornea and possible loss of best-corrected visual acuity. A possibility of under or over correction also exists with the aforementioned refractive surgeries. Furthermore, none of these refractive surgeries can be used to correct all of the above-referenced refractive errors.
Various IOLs have been used to treat cataracts. The first implant of an IOL within the eye to treat cataracts occurred in 1949. This experimental surgery attempted to place the replacement lens in the posterior chamber of the eye behind the iris. Problems such as dislocation after implantation forced abandonment of this approach, and for some period thereafter IOLs were implanted in the anterior chamber of the eye.
Others returned to the practice of inserting the IOL in the area of the eye posterior to the iris, known as the posterior chamber. This is the area where the patient's natural crystalline lens is located. When the IOL is located in this natural location, substantially normal vision may be restored to the patient, and the problems of forward displacement of the vitreous humor and retinal detachment encountered in anterior chamber IOLs are less likely to occur. IOLs implanted in the posterior chamber are disclosed in U.S. Patent Nos. 3,718,870, 3,866,249, 3,913,148, 3,925,825, 4,014,049, 4,041,552, 4,053,953, and 4,285,072. None of these IOLs have accommodation capability.
IOLs capable of focusing offered the wearer the closest possible substitute to the natural crystalline lens. U.S. Patent No. 4,254,509 to Tennant discloses an IOL which moves in an anterior direction upon contraction of the ciliary body and which is located anterior to the iris. Although the Tennant IOL claims to possess accommodation capabilities, it presents the same disadvantages as other anterior chamber lenses. U.S. Patent No.4,253,199 to Banko approaches the problem of providing a focusable IOL in a different manner, by providing a replacement IOL of deformable material sutured to the ciliary body. This IOL functions in much the same manner as the natural crystalline lens, but may cause bleeding because it requires sutures.
U.S. Patent No. 4,409,691 to Levy claims to provide an accommodating IOL positioned within the capsule. This IOL is located in the posterior area of the capsule and is biased toward the fovea or rear of the eye. The Levy IOL is deficient because it requires the ciliary muscle to exert force through the zonules on the capsule in order to compress the haptics inward and drive the optic forward for near vision. However, the ciliary muscles do not exert any force during contraction because the zonules, being flexible filaments, exert only tension, not compression on the capsule. The natural elasticity of the IOL causes the capsule to become more spherical upon contraction of the ciliary muscle. Thus, there is no inward force exerted on the capsule to compress the haptics of the Levy IOL, and therefore accommodate for near vision. Even if such force were somehow available, the Levy IOL's haptics are loaded inward when accommodating for near vision. Since accommodation for near vision is the normal status of the capsule, the Levy IOL's haptics are loaded, reducing the fatigue life of the springlike haptics.
U.S. Patent No. 5,674,282 to Cumming is directed towards an allegedly accommodating IOL for implanting within the capsule of an eye. The Cumming IOL comprises a central optic and two plate haptics which extend radially outward from diametrically opposite sides of the optic and are movable anteriorly and posteriorly relative to the optic. However, the Cumming IOL suffers from the same shortcomings as the Levy IOL in that the haptics are biased anteriorly by pressure from the ciliary bodies. This will eventually lead to pressure necrosis of the ciliary body. Finally, U.S. Patent No. 4,842,601 to Smith discloses an allegedly accommodating IOL having anterior and posterior members which urge against the anterior and posterior walls of the capsule. The muscular action exerted on the capsule will cause the IOL to flatten, thereby changing the focus thereof. The Smith IOL is formed of first and second plastic lens members connected to one another adjacent their peripheral edges so as to provide a cavity therebetween. The connection between the lens members is accomplished by way of a U-shaped flange on the first member which forms an inwardly facing groove for receiving an outwardly extended flange on the second member. The Smith IOL is faulty because the structure of the lens members makes surgical implantation thereof extremely difficult to accomplish, even for highly skilled surgeons. Furthermore, the Smith IOL requires sutures which increases the risk of bleeding. The IOLs discussed above replaced the opaque crystalline lens symptomatic of cataracts through a small incision in the iris and anterior wall of the biological capsule. The IOLs for the treatment of cataracts differed from the present invention in that the present invention utilizes a highly refractive material to compensate for defects in the eye's natural refractive media, e.g, the cornea and the natural crystalline lens. There is a great need in the art for a lightweight IOL which can be used to correct a variety of refractive errors in conjunction with other eye defects which require replacement of the natural crystalline lens, such as cataracts. This IOL should be readily insertable into the capsule and should last for a substantial number of years without damaging any of the eye components.
SUMMARY OF THE INVENTION
The IOL of the present invention addresses this need because it provides a lightweight accommodating IOL, containing a highly refractive material therein, which is safe for long term use in an eye. The present invention presents a significant advance in the art because it provides an IOL for the safe and effective treatment of refractive errors in combination with other defects such as cataracts.
In more detail, the IOL comprises a resilient optic formed of a highly refractive material operably coupled to a flexible optic positioning member to change shape in response to ciliary body movement, i.e., contraction and retraction of the ciliary body. When the ciliary body relaxes or retracts, it causes the zonules to elongate and exert a tensional pull upon the IOL. Thus, the IOL becomes discoid in shape and allows the viewer to focus upon objects located at a distant therefrom. Similarly, when the ciliary body contracts, it becomes thicker and causes the zonules to ease the tensional pull. Thus, the IOL becomes spheroid in shape and allows the viewer to focus upon objects located near to the viewer. As noted above, the optic is formed of refractive material that has an index of refraction of from about 1.36 to 1.5 or higher (e.g., hydrocarbon oil, silicone oil, or silicone gel). In one type of IOL in accordance with the invention, use is made of a pre-formed capsule having a thin, continuous wall wherein the refractive material is enveloped.
The optic maybe coupled with various optic positioning members commonly used in IOL construction depending upon the user's eyesight. The optic maybe positioned within the capsule of the eye such that the anterior surface of the optic faces either the anterior or the posterior portion of the eye. When the optic is positioned to face the posterior portion of the eye, the optic will vault posteriorly in response to contraction of the ciliary body. However, the change in the radius of curvature of the optic will counteract the effects of the negative accommodation, i.e., movement of the optic posteriorly. The resiliency of the optic permits a small change in radius of curvature which, when coupled with the relatively high index of refraction of the refractive material, results in an optic having greater light-bending properties than conventional optics. Another preferred embodiment presents a resilient optic and a posterior rigid optic both operably coupled on opposed sides of an optic positioning member to change shape in response to ciliary body movement. The optics are positioned on opposite segments of the optic positioning members such that they share the same focal point. A similar embodiment transposes the structure described immediately above by implanting the IOL within the eye such that the rigid optic is the anterior optic and the resilient optic is the posterior optic.
Another embodiment of the present invention presents two optics positioned on the same segment of the optic positioning member wherein a rigid optic surrounds a resilient optic. Another embodiment similar to the embodiment discussed immediately above, presents two optics positioned on the same segment of the optic positioning member wherein a resilient optic surrounds a rigid optic. In this embodiment, the resilient optic changes shape in response to ciliary body movement while the rigid optic essentially retains its shape.
Yet another preferred embodiment of the IOL of the present invention includes an optic positioning member comprised of an enclosed flexible bag having resilient fill material therein. The enclosed flexible bag presents an anterior segment and an opposed posterior segment, each having an optic. The optic positioning member is pre-formed to present opposed optic surfaces, hence, the optics are integral with the optic positioning member. The resilient fill material is comprised of the same refractive material used in the above-referenced resilient optic construction. This embodiment also functions similarly to the IOLs discussed above because the anterior optic surface moves anteriorly and the posterior optic surface moves posteriorly in response to contraction of the ciliary body. The optic surfaces of the flexible bag optic positioning member present a small change in the radius of curvature (e.g., 5 - 4.6 mm) from the accommodated to disaccommodated shapes, coupled with high refractive power thereby permitting retinal receipt of an observed image. Another embodiment of the present invention is similar to the embodiments having opposed optics, described above, except that the optic positioning member of this embodiment does not completely house the refractive material. The refractive material of this IOL protrudes outward to extend beyond the outer margins of the anterior segment through an opening in the optic positioning member to define a resilient optic. The posterior segment of the optic positioning member supports a second posterior rigid optic positioned in opposition to the resilient optic. The rigid optic is constructed of the same material as the optic positioning member. The resilient material is captively retained by the segments of the optic positioning member, but also directly contacts the biological capsule. Contraction of the ciliary body transfers sufficient force to the resilient and protuberant refractive material which in turn defines an optic operable to change shape in response to ciliary body movement. This embodiment may be constructed without the addition of a second opposed rigid optic depending upon identifiable surgical needs.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a vertical sectional view showing an IOL of the invention within the capsule of an eye, with the eye focused on an object distant from the viewer;
Fig. 2 is a vertical sectional view of a preferred IOL of the invention; Fig. 3 is an anterior perspective view of the IOL of Figs. 1 and 2; Fig. 4 illustrates another embodiment of the invention; Fig. 5 illustrates another embodiment of the invention; Fig. 6 illustrates another embodiment of the invention;
Fig. 7 is a vertical sectional view of the IOL of Fig. 3 showing the optic bonded to the anterior surface of the anterior segment of the IOL of the present invention;
Fig. 8 is a vertical sectional view of the IOL of Fig. 3 showing the optic bonded to the posterior surface of the anterior segment of the IOL of the invention; Fig. 9 is a vertical sectional view of another embodiment of the invention showing the optic located at the anterior segment of the IOL and a posterior rigid optic at the posterior segment of the IOL;
Fig. 10 is a vertical sectional view of the IOL of Fig.9 positioned within the eye, with the optic located at the posterior segment of the IOL and a rigid optic at the anterior segment; Fig. 11 is a vertical sectional view of a preferred IOL of the invention within the capsule of an eye, with the eye focused on an object distant from the viewer;
Fig. 12 is a view similar to that of Fig. 11, but illustrating the IOL in an accommodated position owing to contraction of the ciliary body;
Fig. 13 is a plan view of a preferred IOL of the invention; Fig. 14 is a vertical sectional view taken along line 14-14 of Fig. 13; Fig. 15 is a greatly enlarged fragmentary of the IOL of Figs. 11-14;
Fig. 16 is a vertical sectional view similar to that of Figs. 7-10, but illustrating the optic constructed without an enveloping capsule;
Fig. 17 is a vertical sectional view of another embodiment of the present invention, illustrating a resilient optic sunounded by a rigid optic;
Fig. 18 is a vertical sectional view of another embodiment of the present invention, showing an IOL of the invention within the capsule of an eye, with the eye focused on an object located at a distance from the viewer; and
Fig.19 is a view similar to that of Fig. 18, but illustrating the IOL in an accommodated position owing to contraction of the ciliary muscle;
Fig. 20 is a vertical sectional view showing an IOL of the invention within the capsule of an eye, with the optic positioned posteriorly;
Fig. 21 is a view similar to that of Fig.20, but illustrating the IOL in a disaccommodated position owing to retraction of the ciliary muscle; Fig. 22 is a vertical sectional view of another embodiment of the IOL of the present invention positioned within the capsule of the eye;
Fig. 23 is a vertical sectional view of another IOL of the invention where the IOL is positioned in the capsule of an eye, with the eye focused on an object distant from the viewer;
Fig. 24 is a view similar to that of Fig. 23, but illustrating the IOL in an accommodated position owing to contraction of the ciliary body;
Fig. 25 is a plan view of the IOL of Figs. 23-24; and
Fig. 26 is a vertical sectional view taken along line 26-26 of Fig. 25.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Referring now to the drawings, the present invention is in the form of an IOL for surgical replacement of the natural crystalline lens in the treatment of refractive error in the human eye. Fig.1 shows the various components of the human eye 10 pertinent to this invention. Briefly, the eye 10 includes an anterior portion 12 and a posterior portion 14. The anterior portion 12 of the eye 10 is covered by a cornea 16 which encloses and forms an anterior chamber 18. The anterior chamber 18 contains aqueous fluid and is bounded at the rear by an iris 20. The iris 20 opens and closes to admit appropriate quantities of light into the inner portions of the eye 10. The eye 10 also includes a capsule 22 which ordinarily contains the natural crystalline lens (which would be located at numeral 24 in the natural, unmodified eye). The eye 10 includes a ciliary muscle or body 26 having zonular fibers 28 (also referred to as zonules) which are attached to the eye 10. The vitreous humor 30 is located posterior to the capsule 22 and anterior to the retina (not pictured). The vitreous humor 30 contains vitreous fluid.
Most of the light entering the eye 10 is refracted at the air - cornea interface. The cornea 16 has an index of refraction of 1.37, and is largely responsible for refracting light into the eye 10. The light then slightly diverges in the fluid- filled anterior chamber 18 which has an index of refraction close to that of water, e.g., approximately 1.33, and travels to the natural crystalline lens 24. The natural crystalline lens 24 is a biconvex structure having an index of refraction of 1.4 at its center and an index of refraction of 1.38 at its outer portion. Next to the cornea 16, the natural crystalline lens 24 is responsible for refracting much of the light entering the human eye 10. The anterior portion of the natural crystalline lens 24 converges light onto its posterior portion where light is then diverged. It is at this point, that the image being viewed is inverted. The inverted image (or light) then travels into the vitreous humor 30 and tluough the vitreous fluid. The vitreous fluid has an index of refraction close to that of water, e.g. 1.33. After the inverted image travels through the vitreous humor 30, it is brought to focus upon the retina. The retina is responsible for relaying electric signals to the optic nerve. The optic nerve then carries the message to the brain which translates the inverted image into its upright position. Ocular adjustments for sharp focusing of objects viewed at different distances are accomplished by the action of the ciliary body 26 on the capsule 22 and natural crystalline lens 24 through the zonules 28. The ciliary body 26 contracts, allowing the capsule 22 to return to a more spherical shape for viewing obj ects near to the viewer. When the ciliary body 26 retracts, the ciliary body 26 pulls on the zonules 28 to make the capsule 22 more discoid thus permitting objects at a distance to be viewed in proper focus. (Fig. 1) To summarize, when the eye 10 focuses, the capsule 22 changes shape to appropriately distribute the light admitted through the cornea 16 and the iris 20.
Referring now to Figs. 1-22, an IOL in accordance with the invention comprises an optic 32 operably coupled to an optic positioning member and implanted within the capsule 22 of the human eye 10. The IOL changes shape in response to ciliary body 26 movement. As previously noted, the optic 32 of the present invention is formed of a highly refractive material. The refractive material has an index of refraction of from about 1.36 to 1.5 or higher. Examples of preferred refractive materials include silicone oil, hydrocarbon oil, and more preferably silicone gel (available from Nusil Technology). When the refractive material used is a gel, the gel may be pre-formed into the desired optic shape and adhered onto the optic positioning member without encapsulating it.
The optic 32 may be utilized in a number of ways in a variety of optic positioning members. The optic positioning members discussed herein are preferably formed of any appropriate biologically inert material conventionally used in IOL construction (e.g., elastic, synthetic resin materials). Examples of suitable materials include acrylates (such as polymethylmethacrylates), silicones, and mixtures of acrylates and silicones. It is contemplated that mixtures of silicones and acrylates comprise both chemical mixtures, such as silicone-acrylate blends, and various combinations of silicones and acrylates employed to construct the lens. It is particularly preferred that the optic positioning members according to the invention be constructed of a material having an elastic memory (i.e., the material should be capable of substantially recovering its original size and shape after a deforming force has been removed). An example of a preferred material having elastic memory is MEMORYLENS (available from Mentor Ophthalmics in California).
The preferred embodiments of the IOL of the instant invention discussed immediately below demonstrate the variety of optic positioning members that maybe operably coupled with the inventive optic to correct refractive enors in the eye. The terms rigid optic and resilient optic are used herein as relative terms to one another. For instance, a rigid optic may be any optic that is less resilient than the resilient optic of the present invention, even though the rigid optic may be more resilient than another rigid optic. The optics of the present invention may be made of varying degrees of resiliency and rigidity depending upon the materials used, therefore, the terms rigid and resilient should not be used as limiting terms other than to convey a specific relationship between two optics within the scope of this invention.
The IOL of Figs. 1-3 [IOL 61]
The optic 32 presents a convex anterior surface 36 and a planar posterior surface 38 (hereinafter plano-convex). Although the optic 32 is illustrated as plano-convex, the size and shape of the optic 32 maybe varied depending upon the user's eyesight. The optic 32 is composed of a refractive material 40 that is enveloped within a pre-formed capsule 42 formed of a thin continuous wall 43 made of the same flexible synthetic resin material as the optic positioning member 34. The thin wall 43 has an anterior section 33 facing the anterior portion 12 of the eye 10 and a posterior section 41 facing the posterior portion 14 of the eye 10 respectively. (See Fig. 2) The anterior section 33 of the thin wall 43 has a thickness of from about 0.0005 to 0.025 mm, and more preferably of about 0.004 mm, when the material used is silicone. The posterior section 41 of the thin wall 43 has a thickness of from about 0.0005 to 0.025 mm, and more preferably of about 0.003 mm, when the material used is silicone. One of ordinary skill in the art will appreciate that the anterior section 33 and the posterior section 41 of the thin wall 43 may also be constructed of uniform thickness. The optic 32 may also be constructed without the refractive material housed within the pre-formed capsule 42 when the refractive material used is the silicone gel material discussed above. (See Fig. 16)
The optic positioning member 34 may be integral with optic 32 or may be structurally distinct. As illustrated, the optic positioning member 34 comprises a main body 35 which includes an annular posterior segment 44 with a central opening 46 and an anterior segment 37. Anterior segment 37 and posterior segment 44 are located on either side of equatorial axis 56. A plurality of circumferentially spaced, arcuate in cross-section positioning legs 48 extend from the segment 44 and are joined to the margin of optic 32, with openings 50 defined between adjacent pairs of the legs 48. As perhaps best seen in Fig. 2, the legs 48 cooperatively present, with the optic 32, a substantially discoid shape with a central chamber 52. However, the legs 48 also define an annular equatorial segment 54 disposed on opposite sides of equatorial axis 56. (See Fig. 2) The overall IOL 61 further presents a central polar axis 58 as shown. Preferably, the outside dimension of the IOL 61 at the equatorial segment 48 is from about 8 to 12 mm. On the other hand, the outside dimension along polar axis 58 is typically from about 1 to 5 mm. These dimensions given immediately above, however, are only representative of some typical dimensions within the ambit of the present invention. A wide range of variance necessarily exists for the dimensions of the IOLs of this invention because a wide degree of biological variance exists. Clearly, the dimensions of the IOLs of the present invention must conform to the size and shape of the eye to be fitted. One of ordinary skill in the art will readily appreciate this. The optic positioning member 34 discussed herein is configured so as to substantially conform with the capsule 22, particularly to the equatorial portion 27 of the capsule 22. This is shown in Figs. 1 and 2 where it will be observed that the equatorial segment 54 of the IOL 61 is in substantially conforming contact with the inner surface of the equatorial portion 27 of capsule 22. This close conforming relationship is maintained notwithstanding the extent of accommodation of IOL 61. IOL 61 is inserted into the human eye 10 in the following manner. An ophthalmic surgeon would remove the natural crystalline lens 24 by conventional methods, leaving an opening 21 in the anterior wall 23 of the capsule 22. IOL 61 is then folded into a compact size for insertion in the capsule 22 through opening 21. Once inserted, the capsule 22 is filled with fluids (e.g., saline solution) which enter the IOL 61 causing IOL 61 to return to its original, non-deformed state as shown in Fig. 1. There is no need to suture the IOL 61 to the capsule 22 because, due to the size and shape of IOL 61 and conformance of the IOL 61 to the capsule 22, the IOL 61 will not rotate or shift within the capsule 22.
Optionally, IOL 61 may be provided with a very thin membrane (not shown) in covering relationship as disclosed inU.S. Patent Application S/N 09/940,018, filed August 27, 2001 , which is incorporated by reference herein. It is contemplated that the membrane would be formed of the same synthetic resin as the optic positioning member 34 but would be much thinner (on the order of a few thousandths of an inch) than the remainder of the optic positioning member 34. The purpose of the membrane is to prevent or at least impede the passage of migratory cells through openings within the IOL 61 and into the inner chamber of the IOL 61. Furthermore, optic positioning member 34 construction is disclosed in previously filed application for U.S. Letters Patent Serial No. entitled Accommodating Intraocular Lens
Implant and U.S. Letters Patent Serial No.09/ 940,018 entitled Intraocular Lens Implant Having Eye Accommodating Capabilities both to the same applicant, which are hereby incorporated by reference herein as is necessary for a full and complete understanding of the present invention. Implantation of the inventive IOL 61 restores normal vision by providing an optic 32 formed of highly refractive material capable of bending light onto the retina. After implantation of the IOL 61 in the human eye 10, light refracts at the air-cornea interface in the same manner as the natural human eye 10. The light travels through the fluid-filled anterior chamber 18 and onto the optic 32. The radius of curvature of the optic 32 changes in response to ciliary body 26 movement, thus affecting the optic's 32 refractive capabilities. Not only does the IOL 61 project an observed image onto the retina, but it also accommodates in response to action of the ciliary body 26 in connection with the zonules 28 to view objects located both near and far from the viewer. When the viewer is observing an image located at a distance, the sensory cells within the retina signal the ciliary body 26 to relax, thus pulling on the zonules 28 to make the capsule 22 more discoid as shown in Fig. 1. In doing so, the polar dimension of the capsule 22 nanows, subsequently causing the polar dimension of the IOL 61 to similarly nanow. Those ordinarily skilled in the art will appreciate that the optic positioning member 34 is operably coupled with the optic 32 of the present invention to change shape in response to ciliary body 26 movement, hi this regard, the movement of the ciliary body 26 causes the optic 32 to move posteriorly and anteriorly, respectively. Contraction of the ciliary body 26 and subsequent relaxation of the zonules 28 will cause the optic 32 to vault anteriorly.
The IOL 61 of the present invention typically has a diopter value of from about 16 to 26. The diopter value of a lens is defined as the reciprocal of the focal length in meters:
Diopter = 1/focal length (m).
Focal length is the distance from the center of the lens to the object being viewed. The focal length must decrease as magnification increases. The diopter value expresses the refractive capacity of a lens which is associated with the radius of curvature of the optics. Generally, an increased diopter value indicates that the optic is thicker and also has a lesser radius of curvature thus possessing greater light-bending capability.
The IOL of Fig. 4 [IOL 60]
The IOL 60 is similar to IOL 61 illustrated in Figs. 1-3. IOL 60 comprises an optic positioning member 62 wherein the optic positioning member 62 presents an anterior segment 66 and a posterior segment 68 each having a central opening therein 67, 69. A plurality of individually continuous, circumferentially spaced, arcuate in cross-section positioning legs 64 extend from anterior segment 66 and are joined to the margin of optic 32, with openings 71 defined between adjacent pairs of the legs 64, by haptic arms 72. The haptic arms 72 extend between the posterior segment 68 to the margin of the optic 32. The haptic arms 72 join the optic 32 and the optic positioning member 62. This embodiment is similar to IOL 61 in that it may also be constructed with a thin membrane as disclosed in U.S. Patent Application S/N 09/940,018, filed August 27, 2001 which has been incorporated by reference herein.
In this embodiment, it is important that the posterior segment 68 of the optic positioning member 62 not be fixed with respect to the posterior portion of the capsule 22. This would not be the case if the posterior segment 68 was continuously connected with the positioning legs 64. While not shown in the figures, the anterior segment 66 may be continuously connected by an annular haptic. IOL 60 is implanted and operates in the same manner as IOL 61. The IOL 60 of the present invention typically has a diopter value of from about 16 to 26.
Furthemiore, optic positioning member 62 construction is disclosed in previously filed application for U.S . Letters Patent Serial No. entitled Accommodating Intraocular Lens
Implant and U.S. Letters Patent Serial No. 09/940,018 entitled Intraocular Lens Implant Having Eye Accommodating Capabilities both to the same applicant, which are hereby incorporated by reference herein as is necessary for a full and complete understanding of the present invention.
The IOL of Fig. 5 [IOL 60a]
A preferred IOL 60a according to the invention is illustrated in Fig 5. Similar to the IOL 60 embodiment described above, this IOL 60a comprises an optic 32 and an optic positioning member 74 presenting an anterior segment 66a and a posterior segment 68a. A plurality of circumferentially spaced, arcuate in cross-section positioning legs 76 extend from the anterior segment 66a to the optic 32. The haptic arm 72a extends posteriorly from the anterior segment 66a to the optic 32. In a further prefened embodiment of IOL 60a, the optic 32 maybe connected to the optic positioning member 74 via a plurality of haptic arms (not shown). The plurality of haptic arms are disposed at various locations about anterior segment 66a and extend posteriorly towards the optic 32. The plurality of legs 76 are continuously attached to each other through continuous sections 80 presenting annular orifices 82 therethrough. This embodiment is similar to IOL 61 and 60 in that it may also be constructed with a thin membrane as disclosed in U.S. Patent Application S/N 09/940,018, filed August 27, 2001 which has been incorporated by reference herein.
IOL 60a is implanted and operates in a similar manner to IOLs 61 and 60. The IOL 60a of the present invention typically has a diopter value of from about 16 to 26. Furthermore, the construction of optic positioning member 74 is disclosed in previously filed application for U.S. Letters Patent Serial No. entitled Accommodating Intraocular Lens Implant and U.S.
Letters Patent Serial No. 09/ 940,018 entitled Intraocular Lens Implant Having Eye Accommodating Capabilities both to the same applicant, which are hereby incorporated by reference herein as is necessary for a full and complete understanding of the present invention.
The IOL of Fig. 6 [IOL 60b]
Figure 6 depicts yet another preferred IOL 60b according to the invention. This IOL 60b also comprises an optic 32 and an optic positioning member 84 presenting an anterior segment 66b and a posterior segment 68b. The optic positioning member 84 further comprises a plurality of circumferentially spaced, arcuate in cross-section positioning legs 88 having openings 86 therein between adjacent pairs of legs 88. In essence, the IOL 60b is configured in much the same fashion as the IOL 60, with the exception that a plurality of haptic arms 72b extend from equatorial segment 54 toward the optic 32. When the IOL 60b is in its original, non-compressed state, the haptic arms 72b are vaulted slightly toward anterior segment 66b. This embodiment is similar to IOL 61, 60, and 60a in that it may also be constructed with a thin membrane as disclosed in U.S. Patent Application S/N 09/940,018, filed August 27, 2001 which has been incorporated by reference herein.
IOL 60b is implanted and operates in a similar manner to IOLs 61 , 60 and 60a. The IOL 60b of the present invention typically has a diopter value of from about 16 to 26. Furthermore, the construction of optic positioning member 84 is disclosed in previously filed application for
U.S. Letters Patent Serial No. entitled Accommodating Intraocular Lens Implant and
U.S. Letters Patent Serial No. 09/ 940,018 entitled Intraocular Lens Implant Having Eye Accommodating Capabilities both to the same applicant, which are hereby incorporated by reference herein as is necessary for a full and complete understanding of the present invention.
The IOL of Figs. 7 and 8 [IOL 61d]
IOL 61d is another embodiment of the present invention. IOL 61d presents a variation upon the structure of IOL 61 wherein the optic 32 is bound to either the anterior surface 31(a) or the posterior surface 31(b) of the optic positioning member 34. IOL 61d operates in and is implanted in the same manner as IOL 61. Notably, IOL 61d illustrated in Figs. 7 and 8 comprises a liquid refractive material 40 enveloped within the capsule 42. The indices of refraction of the wall 43 and the refractive material 40 may be varied to satiate surgical, medical, or manufacturing needs.
The IOL of Figs. 9 and 10 [IOL 61a]
IOL 61a differs from the embodiments discussed thus far in that while the optic 32 is operably coupled to the anterior segment 37 of the optic positioning member, a second rigid optic 90 is operably coupled to the posterior segment 44. The optics 32, 90 are positioned on opposed segments 37, 44 of the optic positioning member such that the optics 32, 90 share the same optical axis. Opposition or opposed in this context is used consistently in this application to mean positioned on the opposite side of equatorial axis 56(a) such that both optics share substantially the same optic axis, and are aligned such that the IOL provides undistorted vision. The posterior optic 90 is made of the same material as the optic positioning member 34, however, one of ordinary skill in the art will recognize that the posterior optic 90 may be constructed of the inventive refractive material as well.
This embodiment is implanted and operates in essentially the same manner as the IOLs discussed thus far, but differs because it includes a second opposed rigid optic 90. The anterior optic 32 converges light upon the posterior optic 90. The posterior optic 90, in turn, diverges the light onto the retina. Any irregularities in the cornea 16 or the natural crystalline lens 24 are counteracted by the highly refractive material 102, thereby bringing the image to focus upon the retina. This embodiment also accommodates in response to ciliary body 26 movement. When the ciliary body 26 contracts, the IOL 61a assumes a spheroid shape. The anterior optic 32 moves anteriorly whereas the posterior optic 90 moves posteriorly. When the ciliary body 26 retracts, the zonules 28 exert a tensional pull upon the IOL to change the IOL to a discoid shape. The anterior optic 32 moves posteriorly whereas the posterior optic 90 moves anteriorly. The IOL 61a of the present invention typically has a diopter value of from about 16 to 26.
IOL 61a may also be positioned within the eye 10 such that the rigid optic 90 is located anteriorly and the optic 32 is positioned posteriorly as illustrated in Figure 10. When the IOL 61a is positioned within the eye 10 in this manner, the IOL 61 has a combined total refraction of about 16 to 26 diopters. The IOL of Figs. 11-15 [IOL 92]
Another prefened embodiment of the present invention includes an anterior optic 94a and a posterior optic surface 96a integral with an optic positioning member 98, such that the IOL 92 presents a unitary structure for implantation within the capsule 22 of the human eye 10. (See Fig. 11) IOL 92 comprises a main body presenting a pre-formed enclosed flexible bag 100 having a resilient fill material 102(a) therein. The pre-formed enclosed flexible bag 100 may also be filled with other refractive media disclosed herein. Flexible bag 100 comprises an anterior segment 104, and a posterior segment 106. Flexible bag further includes wall 112 which, when viewed in cross section, forms and extends radially from an anterior arcuate wall segment 94 and converges upon the posterior segment 106 of the IOL 92 to form an opposing posterior arcuate wall segment 96. The opposing arcuate wall segments 94, 96 define opposed anterior and posterior optic surfaces 94a, 96a when cavity 114 of enclosed flexible bag 100 is filled with material 102(a). Although the terminology 'optic surface' is used herein to describe surfaces 94a and 96a, these surfaces 94a, 96a, operate functionally as optics. Therefore, the term optic may be used interchangeably to describe optic surfaces 94a, 96a within the remainder of this disclosure.
The anterior optic surface 94a and the posterior optic surface 96a have a combined radius of curvature of from about 16 to 26 diopters. (See Fig. 11) The anterior optic surface 94a and the posterior optic surface 96a are both illustrated as convex in shape. When viewed in cross- section, anterior segment 94 and posterior segment 96 are connected by a pair of opposed arcuate equatorial segments 124a as shown in Fig. 14.
Wall 112 includes a fill aperture 118 with a plug therein closing the aperture 118. Although aperture 118 is illustrated at location 120 of the IOL 92, the aperture 118 can be formed at any location on the IOL 92. Preferably the IOL 92 will have an outer equatorial diameter (distance of IOL 92 taken through equatorial axis 124) of from about 8 to 12 mm. (See Fig. 13) Preferably the IOL will have an outside dimension through the central polar axis 122 of from about 2 to 5 mm. (See Fig. 13)
An ophthalmologist fills cavity 114 with material 102(a) prior to surgical implantation of the IOL 92 within the human eye 10 by inserting the material 102(a) through the aperture 118. After cavity 114 is filled, the aperture 118 is sealed. The ophthalmologist removes the natural crystalline lens 24 by conventional methods, leaving an opening in the anterior wall 23(a) of the capsule 22. The IOL 92 is folded an inserted within the capsule 22 through the opening. Implantation of the IOL 92 does not require suturing of the eye 10 be because the instant IOL 92 is capable of being implanted through a small opening in the capsule 22.
IOL 92 operates in the same manner as IOL 61 a because IOL 92 includes opposed optic surfaces 94, 96. Anterior optic 94 converges light upon the posterior optic 96, which in turn, diverges light onto the retina. The IOL 92 responds to contraction of the ciliary body 26 by assuming a spheroid shape.
IOL ofFig l6 [IOL 61] Fig. 16 illustrates optic 32 of the inventive IOL 61 formed from a resilient silicone gel material. Therefore, the IOL 61 of Fig. 16 does not depict the refractive material enveloped within a pre-formed capsule 42 having a thin continuous wall 43. The capsule 42 is not needed when the refractive material is fonned from a resilient, shape-retaining synthetic material such as the silicone gel discussed above.
IOL of Fig 17 [IOL 61c]
Another prefened embodiment of the present invention includes an optic positioning member 34 operably coupled with two optics 142, 144 to change shape in response to ciliary body
26 movement. IOL 61c includes a resilient optic 142 sunounded by a rigid optic 144. The resilient optic 142 is fomied of the refractive material discussed above. The rigid optic 144 is formed of the same material as the optic positioning member 34. Both optics 142, 144 are housed within a pre-formed capsule 42 as described in connection with IOL 61.
IOL 61c operates in a similar manner as the embodiments discussed so far, but differs in that the resilient optic 142 sunounded by the rigid optic 144 maintains a constant volume in response to ciliary body 26 movement. The constant volume of the resilient optic 142 coupled with the relatively high refractive index of the refractive material contained therein confers increased light-bending properties upon the resilient optic 142.
IOL of Figs. 18 and 19 [IOL 200] Another prefened embodiment is an IOL 200 having an annular optic positioning member
210 presenting spaced-apart arcuate anterior 212 and posterior segments 214. The IOL 200 further includes an anterior resilient optic 216 and a posterior rigid optic 218 operably coupled to the optic positioning member 210 to change shape in response to ciliary body 26 movement.
The anterior segment 212 of the optic positioning member 210 contains an opening 220 of from about 7 to 3 mm , and more preferably of about 4 mm wide. The anterior segment 212 further includes an outer margin 222 and an inner margin 224. The outer margin 222 is defined as the anterior portion of the anterior segment 212, or that portion of the segment 212 closest to the iris 20. The posterior segment 214 also includes an inner margin 226 and an outer margin 228 wherein the inner margin 226 of the posterior segment 214 is the margin closest to the iris 20 as well. The space between the anterior segment 212 and the posterior segment 214 is occupied by refractive material such that the refractive material is adj acent to the inner margins 224, 226 of the segments 212, 214. The refractive material protrudes beyond the outer margin 222 of the anterior segment 212. This protrusion defines the resilient optic 216. The refractive material used herein is the refractive silicone gel discussed above. The silicone gel refractive material maybe pre-formed into the desired shape and connected, by posts, to the segments 212, 214 of the optic positioning member 210. The refractive material may also be encompassed within a bladder which is also similarly connected to the segments 212, 214. In this case, the refractive material used may also be a liquid.
The IOL 200 may further include a second rigid optic 218 opposed to resilient optic 216. The rigid optic 218 is made of the same material as the optic positioning member 210 and is supported by the posterior segment 214. As mentioned above, the space between the segments 212, 214 is occupied by refractive material. This IOL 200 differs from the other embodiments discussed herein because the refractive material is not completely contained by the optic positioning member 210 in addition to the optic 216 defining protrusion which extends beyond the outer margin 222 of the anterior segment 212. The refractive material is positioned between the two segments 212, 214 such that the refractive material comes into direct contact with the biological capsule 22 at locations 230.
IOL 200 is implanted in the same manner as IOL 61 after IOL 200 is assembled, and operates in a similar manner to the other IOLs having opposed optics discussed herein. Contraction of the ciliary body 26 and subsequent relaxation of the zonules 28 exerts force upon the refractive material causing the material to protrude outward to extend beyond the outer margin 222 of the anterior segment 212. When the ciliary body 26 retracts, the zonules 28 exert a tensional pull upon the capsule 22, and the refractive material assumes its more flattened shape to view objects located at a distance. IOL of Figs. 20 and 21 [IOL 61b]
The IOL 61b illustrated in Figs.20 and 21 demonstrate yet another prefened embodiment of the invention. Figs. 20 and 21 demonstrate any of the IOLs of Figs. 1-8 and 16 discussed above positioned within the eye 10 such that the optic 32 is positioned posteriorly. One of skill in the art would readily appreciate that although Figs. 20 and 21 illustrate any of the IOLs of Figs. 1-8 and 16 in the vertical sectional view, any of the IOLs of the present invention may be positioned such that the anterior optic faces posteriorly. Fig. 20 illustrates the IOL of the present invention in the accommodated shape. Fig. 21 illustrates the IOL in the disaccommodated shape.
IOL of Fig. 22 [IOL 61e]
IOL 61 e illustrated in Fig. 22 is similar to IOL 61c illustrated in Fig. 17. IOL 61 e differs from IOL 61c in that the resilient optic 142a sunounds the rigid optic 144a. Fig. 22 illustrates IOL 61 e positioned posteriorly in the capsule 22 of the eye 10. The resilient optic 142a changes shape in response to ciliary body 26 movement. The change in curvature of the resilient optic 142a provides about 3 diopters of convergence while the rigid optic 144a essentially maintains its shape.
The IOL of Figs. 23-26 [IOL 146]
Figures 23-26 depict yet another IOL 146 according to the invention. IOL 146 includes an optic 148 and an optic positioning element 150. Optic positioning element 150 comprises a plurality of circumferentially spaced-apart, haptic arms 152. Furthermore, a plurality of circumferentially spaced-apart, arcuate in cross-section, positioning legs 154 are joined with the optic via arms 152 at bight 156, thus causingthe arms 152 and optic 148 to lie substantially within the plane created by the equator of the lens. The legs 154 extend both anteriorly and posteriorly in a curved fashion to form respective anterior segments 155 and posterior segments 157 which are joined on either side of the IOL 146 by annular portions 158 and 160. In the embodiment shown, annular portion 158 is located anterior to the optic 148 while annular portion 160 is located posterior to the optic 148. The IOL 146 illustrated also includes optional openings 162 which can be included to assist with positioning of the IOL 146 within the capsule or to allow fluid communication on either side of the optic 148.
This embodiment is similar to IOL 60 and 61 in that it may also be constructed with a thin membrane between legs 154 as disclosed in U.S. Patent Application S/N 09/940,018, filed August 27, 2001, which has been incorporated by reference herein. Also, rather than being joined by annular portions 158, 160, the legs 154 couldbe freestanding such as is shown in the embodiment of Fig. 4. The legs could be joined only on the anterior side of IOL 146, only on the posterior side of IOL 146, or not joined to one another on either side of IOL 146. Also, while optic 148 is plano-convex in shape, other shapes of optics could be utilized as well. In use, the IOL 146 is implanted as discussed with respect to the previous embodiments.
Furthermore, the IOL 146 achieves accommodation by the same mechanism of the lenses discussed above. That is, because the optic 148 is formed of a flexible, resilient material, and the arms 152 and legs 154 are formed of a material which is stiffer or less resilient than that of the optic 148, when the ciliary body 26 contracts, the zonules 28 relax and allow the IOL 146 to become more spheroid in shape. This causes the arms 152 to move towards the optic 148 which, in turn, causes the diameter of the optic 148 to decrease while increasing the thickness of the optic 148 as shown in Fig. 24. Thus, accommodation is achieved.
Although the invention has been described with reference to the prefened embodiments illustrated in the attached drawing figures, it is noted that equivalents may be employed and substitutions made herein without departing from the scope of the invention as recited in the claims. For example, the IOLs of the present invention may all be constructed in the disaccommodated or accommodated shapes. Also, while the foregoing method of inserting the
IOL into the capsule 22 presumed that a portion of the anterior wall 54 of the capsule 22 would be removed with the natural crystalline lens 24, it will be appreciated that it may be possible to insert the IOL through an incision in the posterior wall 53 of the capsule 22. Furthermore, while the foregoing description discloses that the IOL could be utilized to conect refractive enor, the
IOL maybe used in any situation where the natural crystalline lens 24 should be replaced. For example, the IOL may be used to conect myopia, hyperopia, presbyopia, cataracts, or a combination thereof. Various refractive media may be used to fill cavity 114 of IOL depending upon the desired index of refraction. Furthermore, the optics of each embodiment could be formed of a wide range of flexible, refractive materials. These include gels, silicone, silicone blends, refractive liquids, elastomeric materials, rubbers, acrylates, and mixtures of the foregoing, so long as the material is flexible and resilient.

Claims

I Claim:
1. In an implantable intraocular lens including a light-transmitting optic and adapted for positioning within the capsule of a human eye as a replacement for the natural lens, the improvement which comprises an optic formed from resilient, shape-retaining synthetic material.
2. The lens of claim 1, said material being substantially transparent.
3. The lens of claim 2, said material having an index of refraction of at least aboutl.36.
4. The lens of claim 1 , said material being formed of a biologically inert material.
5. The lens of claim 4, said material comprising silicone.
6. The lens of claim 1 , said material being a gel.
7. The lens of claim 1, said material having an elastic memory.
8. The lens of claim 1 , said lens further comprising a positioning member operably coupled with said optic and responsive to ciliary body movement in order to change the shape of said optic.
9. The lens of claim 8, said positioning member comprising a main body including anterior and posterior segments, said optic being connected to either segment of said positioning member.
10. The lens of claim 9, said lens further including a rigid optic sunounding said resilient optic, said rigid optic formed of synthetic resin material selected from the group consisting of the silicones, acrylates, and mixtures thereof.
11. The lens of claim 8, said positioning member comprising spaced-apart anterior and posterior segments, said optic being connected to either segment of said positioning member.
12. The lens of claim 11, said lens further including a rigid optic opposed to said resilient optic, said rigid optic formed of synthetic resin material selected from the group consisting of the silicones, acrylates, and mixtures thereof.
13. The lens of claim 12, said optics being substantially between and captively retained by said segments.
14. The lens of claim 13, said lens including an optic defining protrusion extending beyond adjacent outer edges of the margins of said anterior segment.
15. The lens of claim 14, said rigid optic being supported by said posterior segment.
16. The lens of claim 8, said positioning member being formed of a synthetic resin material.
17. The lens of claim 16, said synthetic resin material comprising a biologically inert material.
18. The lens of claim 16, said synthetic resin material comprising a material selected from the group consisting of the silicones, acrylates, and mixtures thereof.
19. The lens of claim 1, said lens presenting opposing anterior and posterior optic surfaces.
20. The lens of claim 19, said lens further including a positioning member operably coupled with said anterior and posterior segments, said positioning member comprising a pair of opposed arcuate sections, in cross-section, between the anterior and posterior optic surfaces.
21. The lens of claim 20, said optic comprising an enclosed flexible bag with resilient fill material therein.
22. The lens of claim 21 , said material being substantially transparent.
23. The lens of claim 22, said material having an index of refraction of at least about 1.36.
24. The lens of claim 21 , said material being formed of a biologically inert material.
25. The lens of claim 21, said material being formed of a compound comprising silicone.
26. The lens of claim 21 , said material being a gel.
28. The lens of claim 21, said material having an elastic memory.
29. The lens of claim 21 , said bag further comprising a fill aperture with aplug therein closing the aperture.
30. The lens of claim 1, said lens having an equatorial diameter of from about 8 tol2 mm.
31. The lens of claim 1 , said lens having a polar height of from about 2 to 5 mm.
32. The lens of claim 1, said lens having a diopter value of from about 16 to 26.
33. An implantable intraocular lens comprising: a resilient light-transmitting optic formed of a synthetic light-refractive material; and a flexible positioning member coupled with the optic and operable, when the lens is placed within a human eye capsule, for changing the shape of said lens in response to ciliary body movement.
34. The lens of claim 33, said material being substantially transparent.
35. The lens of claim 34, said material having an index of refraction of at least about 1.36.
36. The lens of claim 33, said material being formed of a biologically inert material.
37. The lens of claim 33, said material being formed of a compound comprised of silicone.
38. The lens of claim 37, said material being formed of a liquid.
39. The lens of claim 33, said material being formed of a compound comprising hydrocarbons.
40. The lens of claim 39, said material being formed of a liquid.
41. The lens of claim 37, said material being formed of a gel.
42. The lens of claim 41 , said lens further comprising a fixed optic formed of synthetic resin material.
43. The lens of claim 39, said liquid enveloped within a capsule having an anterior section and a posterior section.
44. The lens of claim 43, each of said sections individually having a wall thickness of from about 0.0005 to 0.025 mm.
45. An implantable intraocular lens adapted for positioning within the capsule of a human eye as a replacement for the natural lens, said intraocular lens comprising: an optic comprising a resilient, shape-retaining synthetic material; an optic positioning member operably coupled with said optic and responsive to ciliary body movement in order to change the shape of said optic between a first optic shape and a second optic shape, where said second optic shape has a thickness that is greater than said first optic shape, said positioning member comprising a main body including anterior and posterior segments, said optic being connected to said positioning member in a location central to said anterior and posterior segments.
46. The lens of claim 45, said lens having a plane which approximately bisects said lens, said optic being connected to said positioning member so that said optic lies substantially along said plane.
47. The lens of claim 45 , said positioning member comprising a plurality of spaced- apart legs for engaging the capsule of an eye.
48. The lens of claim 47, said lens further comprising a plurality of spaced-apart arms extending radially from said optic.
49. The lens of claim 48, wherein said legs are arcuate in cross-section and include a bight, at least some of said arms being joined with at least some of said legs at said bight.
50. The lens of claim 46, said lens further comprising aplurality of spaced-apart arms extending radially from said optic.
51. The lens of claim 50, said arms extending in a straight line from said optic.
52. The lens of claim 45, said lens further comprising, aplurality of spaced-apart arms extending radially and in a straight line from said optic.
53. The lens of claim 45, said material having an index of refraction of at least aboutl.36.
54. The lens of claim 53, said material being selected from the group consisting of gels, silicone, silicone blends, refractive liquids, elastomeric materials, rubbers, acrylates, and mixtures of the foregoing.
55. The lens of claim 45 , said positioning member comprising a main body including anterior and posterior segments, said optic being connected to either segment of said positioning member.
56. The lens of claim 45, said optics being substantially between and captively retained by said segments.
57. The lens of claim 45, said lens having an equatorial diameter of from about 8 tol2 mm.
58. The lens of claim 45, said lens having a polar height of from about 2 to 5 mm.
59. The lens of claim 45, said lens having a diopter value of from about 16 to 26.
PCT/US2003/034163 2002-10-25 2003-10-27 Capsular intraocular lens implant having a refractive liquid therein WO2004037127A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2005501704A JP4473217B2 (en) 2002-10-25 2003-10-27 Implantable artificial lens
CA2503961A CA2503961C (en) 2002-10-25 2003-10-27 Capsular intraocular lens implant having a refractive liquid therein
EP03809651A EP1562521B1 (en) 2002-10-25 2003-10-27 Non-capsular intraocular lens implant
DE60330492T DE60330492D1 (en) 2002-10-25 2003-10-27 NON-CAPSULAR INTRAOCULAR LENS IMPLANT
AU2003301524A AU2003301524B8 (en) 2002-10-25 2003-10-27 Capsular intraocular lens implant having a refractive material therein
AT03809651T ATE451079T1 (en) 2002-10-25 2003-10-27 NON-CAPSULAR INTRAOCULAR LENS IMPLANT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/280,918 2002-10-25
US10/280,918 US20040082993A1 (en) 2002-10-25 2002-10-25 Capsular intraocular lens implant having a refractive liquid therein

Publications (2)

Publication Number Publication Date
WO2004037127A2 true WO2004037127A2 (en) 2004-05-06
WO2004037127A3 WO2004037127A3 (en) 2004-06-10

Family

ID=32107051

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/034163 WO2004037127A2 (en) 2002-10-25 2003-10-27 Capsular intraocular lens implant having a refractive liquid therein

Country Status (6)

Country Link
US (5) US20040082993A1 (en)
EP (3) EP1562521B1 (en)
AT (1) ATE451079T1 (en)
CA (2) CA2768127C (en)
DE (1) DE60330492D1 (en)
WO (1) WO2004037127A2 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8167941B2 (en) 2008-01-03 2012-05-01 Forsight Labs, Llc Intraocular, accommodating lens and methods of use
US8414646B2 (en) 2007-12-27 2013-04-09 Forsight Labs, Llc Intraocular, accommodating lens and methods of use
US9011532B2 (en) 2009-06-26 2015-04-21 Abbott Medical Optics Inc. Accommodating intraocular lenses
US9039760B2 (en) 2006-12-29 2015-05-26 Abbott Medical Optics Inc. Pre-stressed haptic for accommodating intraocular lens
US9084662B2 (en) 2006-01-17 2015-07-21 Transcend Medical, Inc. Drug delivery treatment device
US9198752B2 (en) 2003-12-15 2015-12-01 Abbott Medical Optics Inc. Intraocular lens implant having posterior bendable optic
US9271830B2 (en) 2002-12-05 2016-03-01 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US9504560B2 (en) 2002-01-14 2016-11-29 Abbott Medical Optics Inc. Accommodating intraocular lens with outer support structure
US9603703B2 (en) 2009-08-03 2017-03-28 Abbott Medical Optics Inc. Intraocular lens and methods for providing accommodative vision
US9636213B2 (en) 2005-09-30 2017-05-02 Abbott Medical Optics Inc. Deformable intraocular lenses and lens systems
US9814568B2 (en) 2005-03-30 2017-11-14 Forsight Vision6, Inc. Accommodating intraocular lens having dual shape memory optical elements
US9814570B2 (en) 1999-04-30 2017-11-14 Abbott Medical Optics Inc. Ophthalmic lens combinations
US9913712B2 (en) 2011-02-04 2018-03-13 Forsight Labs, Llc Intraocular accommodating lens and methods of use
US9968441B2 (en) 2008-03-28 2018-05-15 Johnson & Johnson Surgical Vision, Inc. Intraocular lens having a haptic that includes a cap
US9987125B2 (en) 2012-05-02 2018-06-05 Johnson & Johnson Surgical Vision, Inc. Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
US10159564B2 (en) 2013-11-01 2018-12-25 Lensgen, Inc. Two-part accomodating intraocular lens device
US10285805B2 (en) 2014-03-28 2019-05-14 Forsight Labs, Llc Accommodating intraocular lens
US10485654B2 (en) 2014-07-31 2019-11-26 Lensgen, Inc. Accommodating intraocular lens device
US10526353B2 (en) 2016-05-27 2020-01-07 Lensgen, Inc. Lens oil having a narrow molecular weight distribution for intraocular lens devices
US10647831B2 (en) 2014-09-23 2020-05-12 LensGens, Inc. Polymeric material for accommodating intraocular lenses
US10772721B2 (en) 2010-04-27 2020-09-15 Lensgen, Inc. Accommodating intraocular lens
US10842616B2 (en) 2013-11-01 2020-11-24 Lensgen, Inc. Accommodating intraocular lens device
US10912643B2 (en) 2004-04-29 2021-02-09 Forsight Vision6, Inc. Accommodating intraocular lens assemblies and accommodation measurement implant
US11065107B2 (en) 2015-12-01 2021-07-20 Lensgen, Inc. Accommodating intraocular lens device
EP2906146B1 (en) * 2012-12-17 2022-04-27 Alcon Inc. Capsule expander device
US11376116B2 (en) 2007-08-13 2022-07-05 Ocumetics Technology Corp. Inflatable intra ocular lens/lens retainer
US11523898B2 (en) 2016-10-28 2022-12-13 Forsight Vision6, Inc. Accommodating intraocular lens and methods of implantation
US11707354B2 (en) 2017-09-11 2023-07-25 Amo Groningen B.V. Methods and apparatuses to increase intraocular lenses positional stability

Families Citing this family (170)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030060881A1 (en) 1999-04-30 2003-03-27 Advanced Medical Optics, Inc. Intraocular lens combinations
US7646544B2 (en) * 2005-05-14 2010-01-12 Batchko Robert G Fluidic optical devices
US7780729B2 (en) 2004-04-16 2010-08-24 Visiogen, Inc. Intraocular lens
US8062361B2 (en) * 2001-01-25 2011-11-22 Visiogen, Inc. Accommodating intraocular lens system with aberration-enhanced performance
US20120016349A1 (en) 2001-01-29 2012-01-19 Amo Development, Llc. Hybrid ophthalmic interface apparatus and method of interfacing a surgical laser with an eye
US7025783B2 (en) * 2002-01-14 2006-04-11 Advanced Medical Optics, Inc. Accommodating intraocular lens with integral capsular bag ring
US7150759B2 (en) * 2002-01-14 2006-12-19 Advanced Medical Optics, Inc. Multi-mechanistic accommodating intraocular lenses
US7261737B2 (en) * 2002-12-12 2007-08-28 Powervision, Inc. Accommodating intraocular lens system and method
US8048155B2 (en) * 2002-02-02 2011-11-01 Powervision, Inc. Intraocular implant devices
US20050021139A1 (en) * 2003-02-03 2005-01-27 Shadduck John H. Ophthalmic devices, methods of use and methods of fabrication
US6935743B2 (en) * 2002-02-06 2005-08-30 John H. Shadduck Adaptive optic lens and method of making
US20040082993A1 (en) 2002-10-25 2004-04-29 Randall Woods Capsular intraocular lens implant having a refractive liquid therein
US20040082995A1 (en) * 2002-10-25 2004-04-29 Randall Woods Telescopic intraocular lens implant for treating age-related macular degeneration
US8328869B2 (en) 2002-12-12 2012-12-11 Powervision, Inc. Accommodating intraocular lenses and methods of use
US7217288B2 (en) 2002-12-12 2007-05-15 Powervision, Inc. Accommodating intraocular lens having peripherally actuated deflectable surface and method
US8361145B2 (en) 2002-12-12 2013-01-29 Powervision, Inc. Accommodating intraocular lens system having circumferential haptic support and method
EP1569581A4 (en) * 2002-12-12 2006-09-20 Powervision Lens system for power adjustment using micropumps
CA2507694C (en) * 2002-12-12 2012-07-31 Victor Esch Accommodating intraocular lens system and method
US7247168B2 (en) * 2002-12-12 2007-07-24 Powervision, Inc. Accommodating intraocular lens system and method
US7637947B2 (en) * 2002-12-12 2009-12-29 Powervision, Inc. Accommodating intraocular lens system having spherical aberration compensation and method
US10835373B2 (en) 2002-12-12 2020-11-17 Alcon Inc. Accommodating intraocular lenses and methods of use
US7144423B2 (en) * 2003-11-12 2006-12-05 Mcdonald Marguerite B Intraocular multifocal lens
AU2004297967C1 (en) * 2003-12-05 2011-10-27 Innolene Llc Improved ocular lens
US7806929B2 (en) * 2004-08-27 2010-10-05 Brown David C Intracapsular pseudophakic device
US7806930B2 (en) * 2004-08-27 2010-10-05 Brown David C Device for attachment to a capsule in an eye
US9872763B2 (en) 2004-10-22 2018-01-23 Powervision, Inc. Accommodating intraocular lenses
US7697214B2 (en) 2005-05-14 2010-04-13 Holochip Corporation Fluidic lens with manually-adjustable focus
US8064142B2 (en) * 2005-05-14 2011-11-22 Holochip Corporation Fluidic lens with reduced optical aberration
US8038711B2 (en) * 2005-07-19 2011-10-18 Clarke Gerald P Accommodating intraocular lens and methods of use
WO2007019389A1 (en) * 2005-08-05 2007-02-15 Visiogen, Inc. Accommodating diffractive intraocular lens
US20070032868A1 (en) * 2005-08-08 2007-02-08 Randall Woods Capsular shape-restoring device
US8034107B2 (en) * 2005-09-01 2011-10-11 Stenger Donald C Accommodating intraocular lens
US9629712B2 (en) * 2005-09-01 2017-04-25 Donald C. Stenger Accommodating intraocular lens
JP4927371B2 (en) * 2005-09-28 2012-05-09 興和株式会社 Intraocular lens
US20070088433A1 (en) * 2005-10-17 2007-04-19 Powervision Accommodating intraocular lens system utilizing direct force transfer from zonules and method of use
US8603164B2 (en) * 2005-10-27 2013-12-10 Gholam A. Peyman Adjustable fluidic telescope
US9681800B2 (en) 2005-10-27 2017-06-20 The Arizona Board Of Regents On Behalf Of The University Of Arizona Holographic adaptive see-through phoropter
US8241355B2 (en) * 2005-10-28 2012-08-14 Abbott Medical Optics Inc. Haptic for accommodating intraocular lens
US7981155B2 (en) * 2005-12-07 2011-07-19 C&C Vision International Limited Hydrolic accommodating intraocular lens
US20070129800A1 (en) * 2005-12-07 2007-06-07 C&C Vision International Limited Hydrolic accommodating intraocular lens
US7985253B2 (en) * 2005-12-07 2011-07-26 C&C Vision International Limited Hydrolic accommodating intraocular lens
US20070168027A1 (en) * 2006-01-13 2007-07-19 Brady Daniel G Accommodating diffractive intraocular lens
US20080077238A1 (en) 2006-09-21 2008-03-27 Advanced Medical Optics, Inc. Intraocular lenses for managing glare, adhesion, and cell migration
US20080154811A1 (en) * 2006-12-21 2008-06-26 Caterpillar Inc. Method and system for verifying virtual sensors
CA2673388C (en) 2006-12-22 2015-11-24 Amo Groningen B.V. Accommodating intraocular lens, lens system and frame therefor
US7713299B2 (en) * 2006-12-29 2010-05-11 Abbott Medical Optics Inc. Haptic for accommodating intraocular lens
CA2674018C (en) 2006-12-29 2015-05-26 Advanced Medical Optics, Inc. Multifocal accommodating intraocular lens
WO2008103798A2 (en) * 2007-02-21 2008-08-28 Powervision, Inc. Polymeric materials suitable for ophthalmic devices and methods of manufacture
WO2009015226A2 (en) 2007-07-23 2009-01-29 Powervision, Inc. Accommodating intraocular lenses and methods of use
EP2647353B1 (en) 2007-07-23 2014-12-31 PowerVision, Inc. Lens delivery system
US8968396B2 (en) 2007-07-23 2015-03-03 Powervision, Inc. Intraocular lens delivery systems and methods of use
US8314927B2 (en) * 2007-07-23 2012-11-20 Powervision, Inc. Systems and methods for testing intraocular lenses
EP2178462B1 (en) 2007-07-23 2014-04-02 PowerVision, Inc. Post-implant lens power modification
US8668734B2 (en) 2010-07-09 2014-03-11 Powervision, Inc. Intraocular lens delivery devices and methods of use
US8974526B2 (en) 2007-08-27 2015-03-10 Amo Groningen B.V. Multizonal lens with extended depth of focus
US8740978B2 (en) * 2007-08-27 2014-06-03 Amo Regional Holdings Intraocular lens having extended depth of focus
US20090062911A1 (en) * 2007-08-27 2009-03-05 Amo Groningen Bv Multizonal lens with extended depth of focus
US9216080B2 (en) * 2007-08-27 2015-12-22 Amo Groningen B.V. Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same
US8747466B2 (en) * 2007-08-27 2014-06-10 Amo Groningen, B.V. Intraocular lens having extended depth of focus
US20090118828A1 (en) * 2007-11-06 2009-05-07 Altmann Griffith E Light-adjustable multi-element ophthalmic lens
ATE523810T1 (en) 2008-02-15 2011-09-15 Amo Regional Holdings SYSTEM, GLASS LENS AND METHOD FOR EXPANDING THE DEPTH OF FOCUS
US8439498B2 (en) 2008-02-21 2013-05-14 Abbott Medical Optics Inc. Toric intraocular lens with modified power characteristics
US8231219B2 (en) * 2008-04-24 2012-07-31 Amo Groningen B.V. Diffractive lens exhibiting enhanced optical performance
US7871162B2 (en) * 2008-04-24 2011-01-18 Amo Groningen B.V. Diffractive multifocal lens having radially varying light distribution
US8862447B2 (en) 2010-04-30 2014-10-14 Amo Groningen B.V. Apparatus, system and method for predictive modeling to design, evaluate and optimize ophthalmic lenses
US20100082017A1 (en) 2008-09-26 2010-04-01 Advanced Medical Optics, Inc. Laser modification of intraocular lens
US8043372B2 (en) * 2008-10-14 2011-10-25 Abbott Medical Optics Inc. Intraocular lens and capsular ring
US10299913B2 (en) 2009-01-09 2019-05-28 Powervision, Inc. Accommodating intraocular lenses and methods of use
US9164202B2 (en) 2010-02-16 2015-10-20 Holochip Corporation Adaptive optical devices with controllable focal power and aspheric shape
EP2470118A1 (en) * 2009-08-27 2012-07-04 Abbott Medical Optics Inc. Fixation of opthalmic implants
US8447086B2 (en) 2009-08-31 2013-05-21 Powervision, Inc. Lens capsule size estimation
US20110071628A1 (en) * 2009-09-24 2011-03-24 Rainbow Medical Ltd. Accommodative intraocular lens
US8518028B2 (en) * 2009-09-30 2013-08-27 Abbott Medical Optics Inc. Methods for enhancing accommodation of a natural lens of an eye
US9278026B2 (en) 2009-09-30 2016-03-08 Abbott Medical Optics Inc. Capsular membrane treatments to increase accommodative amplitude
US9445889B2 (en) * 2009-09-30 2016-09-20 Abbott Medical Optics Inc. Capsular membrane implants to increase accommodative amplitude
CN102892380B (en) * 2009-12-18 2016-10-19 Amo格罗宁根私人有限公司 Single micro structure eyeglass, system and method
JP2013520291A (en) 2010-02-23 2013-06-06 パワーヴィジョン・インコーポレーテッド Liquid for accommodation type intraocular lens
US10278810B2 (en) * 2010-04-29 2019-05-07 Ojo, Llc Injectable physiologically adaptive intraocular lenses (IOL's)
US9220590B2 (en) 2010-06-10 2015-12-29 Z Lens, Llc Accommodative intraocular lens and method of improving accommodation
US9351825B2 (en) 2013-12-30 2016-05-31 James Stuart Cumming Semi-flexible posteriorly vaulted acrylic intraocular lens for the treatment of presbyopia
US9585745B2 (en) 2010-06-21 2017-03-07 James Stuart Cumming Foldable intraocular lens with rigid haptics
US10736732B2 (en) 2010-06-21 2020-08-11 James Stuart Cumming Intraocular lens with longitudinally rigid plate haptic
US8734512B2 (en) 2011-05-17 2014-05-27 James Stuart Cumming Biased accommodating intraocular lens
US9918830B2 (en) 2010-06-21 2018-03-20 James Stuart Cumming Foldable intraocular lens with rigid haptics
US9295545B2 (en) 2012-06-05 2016-03-29 James Stuart Cumming Intraocular lens
US9295544B2 (en) 2012-06-05 2016-03-29 James Stuart Cumming Intraocular lens
US8523942B2 (en) 2011-05-17 2013-09-03 James Stuart Cumming Variable focus intraocular lens
FR2963229B1 (en) * 2010-07-27 2013-07-12 Philippe Sourdille INTRAOCULAR IMPLANT WITH HANGING ELEMENTS.
EP2646872A1 (en) 2010-12-01 2013-10-09 AMO Groningen B.V. A multifocal lens having an optical add power progression, and a system and method of providing same
US8894204B2 (en) 2010-12-17 2014-11-25 Abbott Medical Optics Inc. Ophthalmic lens, systems and methods having at least one rotationally asymmetric diffractive structure
US9931200B2 (en) 2010-12-17 2018-04-03 Amo Groningen B.V. Ophthalmic devices, systems, and methods for optimizing peripheral vision
US9295546B2 (en) 2013-09-24 2016-03-29 James Stuart Cumming Anterior capsule deflector ridge
WO2012129407A2 (en) 2011-03-24 2012-09-27 Powervision, Inc. Intraocular lens loading systems and methods of use
US9186243B2 (en) 2011-05-31 2015-11-17 Novartis Ag Accommodative intraocular lens and method of implantation
US8608800B2 (en) * 2011-08-02 2013-12-17 Valdemar Portney Switchable diffractive accommodating lens
US20130110234A1 (en) * 2011-10-28 2013-05-02 Lauren DeVita Dual optic accommodating iol with low refractive index gap material
US10433949B2 (en) 2011-11-08 2019-10-08 Powervision, Inc. Accommodating intraocular lenses
US8574295B2 (en) 2012-01-17 2013-11-05 Vista Ocular, Llc Accommodating intra-ocular lens system
US8500806B1 (en) * 2012-01-31 2013-08-06 Andrew F. Phillips Accommodating intraocular lens
US8900300B1 (en) 2012-02-22 2014-12-02 Omega Ophthalmics Llc Prosthetic capsular bag and method of inserting the same
US8945215B2 (en) 2012-05-10 2015-02-03 Abbott Medical Optics Inc. Accommodating intraocular lens with a compressible inner structure
US9364318B2 (en) 2012-05-10 2016-06-14 Z Lens, Llc Accommodative-disaccommodative intraocular lens
US9427312B2 (en) * 2012-05-25 2016-08-30 California Institute Of Technology Accommodating intraocular composite lens and related methods
DE102012016892A1 (en) * 2012-08-24 2014-02-27 Be Innovative Gmbh Intraocular lens, in particular ciliary intraocular lens
DE102012016893A1 (en) * 2012-08-24 2014-05-15 Be Innovative Gmbh Intraocular lens, in particular capsular bag intraocular lens
KR20150050588A (en) 2012-08-31 2015-05-08 에이엠오 그로닌겐 비.브이. Multi-ring lens, systems and methods for extended depth of focus
ES2457840B1 (en) 2012-09-28 2015-02-16 Universidad De Murcia Variable power accommodative intraocular lens and variable power accommodative intraocular lens set and capsular ring
CA2877203A1 (en) 2012-12-04 2014-06-12 Amo Groningen B.V. Lenses, systems and methods for providing binocular customized treatments to correct presbyopia
WO2014099345A1 (en) * 2012-12-18 2014-06-26 Novartis Ag Presbyopia-correcting iol using curvature change of an air chamber
WO2014100325A1 (en) 2012-12-21 2014-06-26 Abbott Medical Optics Inc. Accommodating intraocular lens providing progressive power change
US9186244B2 (en) 2012-12-21 2015-11-17 Lensgen, Inc. Accommodating intraocular lens
CN104869946A (en) * 2012-12-21 2015-08-26 诺华股份有限公司 Curvature changing accommodative intraocular lens
US9925039B2 (en) 2012-12-26 2018-03-27 Rainbow Medical Ltd. Accommodative intraocular lens
US10258462B2 (en) 2012-12-26 2019-04-16 Rainbow Medical Ltd. Accommodative intraocular lens
TWI594743B (en) * 2012-12-27 2017-08-11 Bionic artificial crystal body
US9486311B2 (en) 2013-02-14 2016-11-08 Shifamed Holdings, Llc Hydrophilic AIOL with bonding
EP2945571B1 (en) 2013-02-28 2018-04-25 HONIGSBAUM, Richard F. Tensioning rings for anterior capsules and accommodative intraocular lenses for use therewith
AU2014228357B2 (en) 2013-03-11 2018-08-23 Johnson & Johnson Surgical Vision, Inc. Intraocular lens that matches an image surface to a retinal shape, and method of designing same
US9554891B2 (en) 2013-03-14 2017-01-31 Amo Groningen B.V. Apparatus, system, and method for providing an implantable ring for altering a shape of the cornea
EP3785668A1 (en) 2013-03-15 2021-03-03 Alcon Inc. Intraocular lens storage and loading devices and methods of use
US10195018B2 (en) 2013-03-21 2019-02-05 Shifamed Holdings, Llc Accommodating intraocular lens
EP2976042B1 (en) 2013-03-21 2023-09-13 Shifamed Holdings, LLC Accommodating intraocular lens
EP3081192A4 (en) * 2013-12-13 2017-08-09 Xlens Technologies Inc. Adjustable intraocular lens
US20150173892A1 (en) * 2013-12-23 2015-06-25 Novartis Ag Accommodating intraocular lens
US9615916B2 (en) 2013-12-30 2017-04-11 James Stuart Cumming Intraocular lens
WO2016038470A2 (en) 2014-03-10 2016-03-17 Amo Groningen B.V. Dual-optic intraocular lens that improves overall vision where there is a local loss of retinal function
WO2015177651A1 (en) 2014-04-21 2015-11-26 Amo Groningen B.V. Ophthalmic devices, system and methods that improve peripheral vision
CA2952809C (en) 2014-06-19 2019-11-26 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods
CN110279494B (en) 2014-08-26 2023-02-17 施菲姆德控股有限责任公司 Accommodating intraocular lens
JP6564031B2 (en) * 2014-12-09 2019-08-21 ノバルティス アーゲー Adjustable curvature change intraocular lens
US9358103B1 (en) 2015-02-10 2016-06-07 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods
CA2973684C (en) * 2015-03-03 2023-03-14 Novartis Ag Dual optic, curvature changing accommodative iol
US9681945B2 (en) * 2015-09-15 2017-06-20 Mohsen Shahinpoor Double accommodating intraocular accordion lens
US10702375B2 (en) * 2015-09-18 2020-07-07 Vista Ocular, Llc Electromyographic sensing and vision modification
WO2017079733A1 (en) 2015-11-06 2017-05-11 Powervision, Inc. Accommodating intraocular lenses and methods of manufacturing
US11141263B2 (en) * 2015-11-18 2021-10-12 Shifamed Holdings, Llc Multi-piece accommodating intraocular lens
EP3932367A1 (en) * 2015-11-18 2022-01-05 Shifamed Holdings, LLC Multi-piece accommodating intraocular lens
CA3013856A1 (en) 2016-02-09 2017-08-17 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture
ES2631354B1 (en) 2016-02-29 2019-10-09 Univ Murcia INTRAOCULAR OPENING CORRECTING LENS
US9931202B2 (en) * 2016-03-08 2018-04-03 Novartis Ag Dual optic, curvature changing accommodative IOL having a fixed disaccommodated refractive state
CA3017293A1 (en) 2016-03-11 2017-09-14 Amo Groningen B.V. Intraocular lenses that improve peripheral vision
EP3432768B1 (en) 2016-03-23 2020-04-29 Johnson & Johnson Surgical Vision, Inc. Power calculator for an ophthalmic apparatus with corrective meridians having extended tolerance or operation band
WO2017165660A1 (en) 2016-03-23 2017-09-28 Abbott Medical Optics Inc. Ophthalmic apparatus with corrective meridians having extended tolerance band
AU2017252020B2 (en) 2016-04-19 2021-11-11 Amo Groningen B.V. Ophthalmic devices, system and methods that improve peripheral vision
US10327886B2 (en) 2016-06-01 2019-06-25 Rainbow Medical Ltd. Accomodative intraocular lens
CA3026494C (en) 2016-06-06 2022-06-07 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods
US20190262126A1 (en) * 2016-07-19 2019-08-29 Arthur Bernard CUMMINGS Artificial accommodating lens complex
JP7074960B2 (en) 2016-08-24 2022-05-25 カール ツァイス メディテック アーゲー Dual Mode Adjustable-Non-Adjustable Intraocular Lens
EP3954326A1 (en) 2016-10-21 2022-02-16 Omega Ophthalmics LLC Prosthetic capsular device
WO2018078439A2 (en) 2016-10-25 2018-05-03 Amo Groningen B.V. Realistic eye models to design and evaluate intraocular lenses for a large field of view
USD822296S1 (en) * 2016-11-10 2018-07-03 Hyper Pet Llc Pet toy
US10350056B2 (en) 2016-12-23 2019-07-16 Shifamed Holdings, Llc Multi-piece accommodating intraocular lenses and methods for making and using same
US10441411B2 (en) 2016-12-29 2019-10-15 Rainbow Medical Ltd. Accommodative intraocular lens
WO2018167302A1 (en) 2017-03-17 2018-09-20 Amo Groningen B.V. Diffractive intraocular lenses for extended range of vision
US10739227B2 (en) 2017-03-23 2020-08-11 Johnson & Johnson Surgical Vision, Inc. Methods and systems for measuring image quality
WO2018222579A1 (en) 2017-05-30 2018-12-06 Shifamed Holdings, Llc Surface treatments for accommodating intraocular lenses and associated methods and devices
EP3634309B1 (en) 2017-06-07 2023-05-24 Shifamed Holdings, LLC Adjustable optical power intraocular lenses
EP3415117A1 (en) * 2017-06-15 2018-12-19 Laser Vista AG Intraocular lens implant
US11523897B2 (en) 2017-06-23 2022-12-13 Amo Groningen B.V. Intraocular lenses for presbyopia treatment
EP3639084A1 (en) 2017-06-28 2020-04-22 Amo Groningen B.V. Extended range and related intraocular lenses for presbyopia treatment
CA3067116A1 (en) 2017-06-28 2019-01-03 Amo Groningen B.V. Diffractive lenses and related intraocular lenses for presbyopia treatment
US11327210B2 (en) 2017-06-30 2022-05-10 Amo Groningen B.V. Non-repeating echelettes and related intraocular lenses for presbyopia treatment
CA3082053A1 (en) 2017-11-30 2019-06-06 Amo Groningen B.V. Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof
AU2019249216A1 (en) 2018-04-06 2020-10-01 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods
USD900209S1 (en) * 2018-08-22 2020-10-27 Alessandra Marzano Charm for eyeglasses
AU2020357870A1 (en) 2019-10-04 2022-04-28 Alcon Inc. Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses
CN115380239A (en) 2019-12-30 2022-11-22 阿莫格罗宁根私营有限公司 Lens with irregular width diffraction profile for vision treatment
US11886046B2 (en) 2019-12-30 2024-01-30 Amo Groningen B.V. Multi-region refractive lenses for vision treatment
US11759309B2 (en) 2020-04-29 2023-09-19 Long Bridge Medical, Inc. Devices to support and position an intraocular lens within the eye and methods of use
WO2022082170A1 (en) 2020-10-12 2022-04-21 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217612B1 (en) * 1999-09-10 2001-04-17 Randall Woods Intraocular lens implant having eye accommodating capabilities
US6299641B1 (en) * 1999-09-10 2001-10-09 Randall Woods Intraocular lens implant having eye accommodating capabilities
US6645246B1 (en) * 1999-09-17 2003-11-11 Advanced Medical Optics, Inc. Intraocular lens with surrounded lens zone

Family Cites Families (336)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25286E (en) 1962-11-13 Bifocal corneal contact lens
US601301A (en) * 1898-03-29 ihlder
US1483509A (en) * 1921-05-05 1924-02-12 Franklin Optical Company Process of making fused bifocal lenses
US2129305A (en) 1936-08-21 1938-09-06 Feinbloom William Contact lens
US2274142A (en) * 1940-01-15 1942-02-24 Revalens Co Multifocal ophthalmic lens
US2405989A (en) 1941-08-12 1946-08-20 Beach Lens Corp Lens
US2511517A (en) 1947-01-31 1950-06-13 Bell & Howell Co Method of producing optical glass of varied refractive index
US3004470A (en) 1956-07-28 1961-10-17 Zeiss Ikon A G Stuttgart Multiple focal length lens
US2834023A (en) * 1957-02-06 1958-05-13 Titmus Optical Company Inc Anterior chamber lenses for refractive correction of aphakia, high ametropia, and anisometropia
US3031927A (en) * 1958-03-03 1962-05-01 Plastic Contact Lens Company Bifocal corneal contact lens
US3034403A (en) * 1959-04-03 1962-05-15 Neefe Hamilton Res Company Contact lens of apparent variable light absorption
US3227507A (en) * 1961-08-16 1966-01-04 Feinbloom William Corneal contact lens having inner ellipsoidal surface
US3339997A (en) 1962-07-30 1967-09-05 Plastic Contact Lens Company Bifocal ophthalmic lens having different color distance and near vision zones
US3210894A (en) 1962-08-13 1965-10-12 Kollmorgen Corp Method of producing aspheric surfaces on mirrors or lenses
US3420006A (en) * 1964-01-27 1969-01-07 Howard J Barnett Apparatus for grinding multifocal lens
US3431327A (en) * 1964-08-31 1969-03-04 George F Tsuetaki Method of making a bifocal contact lens with an embedded metal weight
US3482906A (en) 1965-10-04 1969-12-09 David Volk Aspheric corneal contact lens series
US3542461A (en) 1967-11-20 1970-11-24 Du Pont Contact lens having an index of refraction approximating that of human tears
US3673616A (en) * 1970-01-16 1972-07-04 Svyatoslav Nikolaevich Fedorov Artificial anterior chamber lens
FR2097216A5 (en) 1970-05-27 1972-03-03 Anvar
US3673816A (en) * 1971-03-05 1972-07-04 Jones & Laughlin Steel Corp Coupling arrangement
US3718870A (en) * 1971-08-12 1973-02-27 Itt Driving circuit for electro-mechanical oscillators
US3711870A (en) * 1971-12-07 1973-01-23 R Deitrick Artificial lens implant
US4055378A (en) 1971-12-31 1977-10-25 Agfa-Gevaert Aktiengesellschaft Silicone contact lens with hydrophilic surface treatment
BE795326A (en) * 1972-02-28 1973-05-29 Lapeyre Gabriel E R DENTAL PROSTHESIS FIXATION DEVICE
US3794414A (en) * 1972-05-12 1974-02-26 Jessen Inc Wesley Multiple focal contact lens
CA1012392A (en) 1973-08-16 1977-06-21 American Optical Corporation Progressive power ophthalmic lens
US3906551A (en) * 1974-02-08 1975-09-23 Klaas Otter Artificial intra-ocular lens system
US3866249A (en) * 1974-03-07 1975-02-18 Leonard Flom Posterior chamber artificial intraocular lens
US3922728A (en) 1974-08-15 1975-12-02 Krasnov Mikhail M Artificial crystalline lens
US3913148A (en) 1974-12-26 1975-10-21 Ernst W Potthast Intraocular lens apparatus
US3932148A (en) * 1975-01-21 1976-01-13 Criterion Manufacturing Company, Inc. Method and apparatus for making complex aspheric optical surfaces
US3925825A (en) 1975-01-24 1975-12-16 American Optical Corp Supporting system for artificial intraocular lens
US4010499A (en) * 1975-07-17 1977-03-08 Davis Alden B Invalid transport
US4010496A (en) * 1975-10-01 1977-03-08 Neefe Charles W Bifocal lens which positions within the anterior chamber
US4053953A (en) 1976-01-14 1977-10-18 Leonard Flom Posterior chamber artificial intraocular lens with retaining means and instruments for use therewith adapted to provide extraocular confirmation of operative engagement
DE2610203B2 (en) 1976-03-11 1981-01-22 Optische Werke G. Rodenstock, 8000 Muenchen Progressive lens
US4056855A (en) 1976-04-07 1977-11-08 Charles Kelman Intraocular lens and method of implanting same
US4014049A (en) * 1976-04-07 1977-03-29 American Optical Corporation Artificial intraocular lens and supporting system therefor
US4073579A (en) * 1976-06-09 1978-02-14 American Optical Corporation Ophthalmic lens with locally variable index of refraction and method of making same
US4041552A (en) * 1976-09-01 1977-08-16 Fotios Ganias Artificial lens
US4074368A (en) * 1976-09-08 1978-02-21 Said Chauncey F. Levy, Jr., By Said Richard J. Pegis Intraocular lens with high magnification
DE2702117A1 (en) 1977-01-20 1978-07-27 Soehnges Optik Loose-seat contact lens - has surface structures on securing surface against corneal surface formed by moulding
US4087866A (en) * 1977-04-26 1978-05-09 Coburn Optical Industries, Inc. Intraocular lens
US4110848A (en) * 1977-05-06 1978-09-05 Ronald P. Jensen Intraocular lens for implantation into the posterior chamber of a human eye
US4159546A (en) * 1977-06-15 1979-07-03 Shearing Steven P Intraocular lens
US4162122A (en) 1977-09-14 1979-07-24 Cohen Allen L Zonal bifocal contact lens
US4210391A (en) 1977-09-14 1980-07-01 Cohen Allen L Multifocal zone plate
US4195919A (en) * 1977-10-31 1980-04-01 Shelton William A Contact lens with reduced spherical aberration for aphakic eyes
WO1987000299A1 (en) 1985-06-24 1987-01-15 Leonard Bronstein Contact lens
DE2814916C3 (en) * 1978-04-06 1982-01-07 Optische Werke G. Rodenstock, 8000 München Spectacle lens with a progression area located between the far part and the near part
US4199231A (en) 1978-08-21 1980-04-22 Evans Carl H Hydrogel contact lens
US4253199A (en) * 1978-09-25 1981-03-03 Surgical Design Corporation Surgical method and apparatus for implants for the eye
US4244060A (en) * 1978-12-01 1981-01-13 Hoffer Kenneth J Intraocular lens
US4340283A (en) 1978-12-18 1982-07-20 Cohen Allen L Phase shift multifocal zone plate
US4338005A (en) 1978-12-18 1982-07-06 Cohen Allen L Multifocal phase place
US4251887A (en) * 1979-04-02 1981-02-24 Anis Aziz Y Posterior chamber capsular lens implant and method for implantation of the lens
US4254509A (en) * 1979-04-09 1981-03-10 Tennant Jerald L Accommodating intraocular implant
US4285072A (en) * 1979-05-14 1981-08-25 Harry H. Leveen Anterior-posterior intraocular lens
US4274717A (en) 1979-05-18 1981-06-23 Younger Manufacturing Company Ophthalmic progressive power lens and method of making same
US4244597A (en) * 1979-05-29 1981-01-13 Dandl John E Side mounting assembly for tractor implement
US4261065A (en) * 1979-07-27 1981-04-14 Tennant Jerald L Artificial intraocular lens with forward-positioned optics
JPS5942286B2 (en) 1979-08-24 1984-10-13 セイコーエプソン株式会社 eyeglass lenses
US4316293A (en) * 1979-08-27 1982-02-23 Bayers Jon Herbert Flexible intraocular lens
US4418991A (en) 1979-09-24 1983-12-06 Breger Joseph L Presbyopic contact lens
US4298994A (en) 1979-10-26 1981-11-10 Clayman Henry M Posterior chamber intra-ocular transplant device
US4315336A (en) * 1980-01-21 1982-02-16 Stanley Poler Intraocular lens
US4307945A (en) 1980-02-14 1981-12-29 Itek Corporation Progressively varying focal power opthalmic lens
US4377329A (en) * 1980-02-26 1983-03-22 Stanley Poler Contact lens or the like
USRE32525F1 (en) 1980-04-01 1989-05-09 Universal intraocular lens and a method of measuring an eye chamber size
US4377873A (en) * 1980-10-30 1983-03-29 Reichert Jr Henry L Intraocular lens
US4373218A (en) * 1980-11-17 1983-02-15 Schachar Ronald A Variable power intraocular lens and method of implanting into the posterior chamber
US4575878A (en) * 1981-01-30 1986-03-18 Seymour Dubroff Intraocular lenses
US4340979A (en) 1981-03-18 1982-07-27 Kelman Charles D Intraocular lens
US4370760A (en) * 1981-03-25 1983-02-01 Kelman Charles D Anterior chamber intraocular lens
US4361913A (en) 1981-04-03 1982-12-07 Streck Donald A Intraocular lens
DE3265356D1 (en) 1981-04-29 1985-09-19 Pilkington Perkin Elmer Ltd Artificial eye lenses
DE3119002A1 (en) * 1981-05-13 1982-12-02 INPROHOLD Establishment, 9490 Vaduz REAR CHAMBER IMPLANTATION LENS
US4402579A (en) 1981-07-29 1983-09-06 Lynell Medical Technology Inc. Contact-lens construction
US4442553A (en) * 1981-09-17 1984-04-17 Hessburg Philip C Intraocular lens
US4504981A (en) * 1981-09-28 1985-03-19 Walman Gerald B Intraocular lens
US4409691A (en) 1981-11-02 1983-10-18 Levy Chauncey F Focussable intraocular lens
US4573998A (en) * 1982-02-05 1986-03-04 Staar Surgical Co. Methods for implantation of deformable intraocular lenses
US5776191A (en) 1982-02-05 1998-07-07 Staar Surgical Company Fixation system for intraocular lens structures
US4702244A (en) 1982-02-05 1987-10-27 Staar Surgical Company Surgical device for implantation of a deformable intraocular lens
US4404694A (en) 1982-03-18 1983-09-20 Kelman Charles D Intraocular lens
US4503953A (en) * 1982-06-01 1985-03-12 Rockwell International Corporation Roller retainer for brake assembly
US4512040A (en) * 1982-06-09 1985-04-23 Mcclure Hubert L Bifocal intraocular lens
DE3222099C2 (en) 1982-06-11 1984-06-20 Titmus Eurocon Kontaktlinsen Gmbh & Co Kg, 8750 Aschaffenburg Bifocal contact lens of the bivisual type
GB2124500B (en) 1982-07-22 1986-04-30 Mazzocco Thomas R Improved fixation system for intraocularers structures
US4504982A (en) * 1982-08-05 1985-03-19 Optical Radiation Corporation Aspheric intraocular lens
US4573775A (en) * 1982-08-19 1986-03-04 Vistakon, Inc. Bifocal contact lens
US4888015A (en) 1982-08-20 1989-12-19 Domino Rudolph S Method of replacing an eye lens
EP0104832B1 (en) * 1982-09-29 1987-11-11 Pilkington Brothers P.L.C. Improvements in or relating to ophthalmic lenses
US4476591A (en) 1982-10-07 1984-10-16 Arnott Eric J Lens implants for insertion in the human eye
US4890913A (en) * 1982-10-13 1990-01-02 Carle John T De Zoned multi-focal contact lens
DE3381691D1 (en) 1982-10-13 1990-08-02 Ng Trustees & Nominees Ltd BIFOCAL CONTACT LENSES.
GB2129157B (en) * 1982-10-27 1986-02-05 Pilkington Perkin Elmer Ltd Bifocal contact lenses having defractive power
US4463458A (en) 1982-11-08 1984-08-07 Vision Laboratories Inc. Intraocular lens and implantation method
DE3246306A1 (en) 1982-12-14 1984-06-14 Titmus Eurocon Kontaktlinsen Gmbh & Co Kg, 8750 Aschaffenburg Bifocal lens of bivisual type
US4580882A (en) * 1983-04-21 1986-04-08 Benjamin Nuchman Continuously variable contact lens
US4617023A (en) 1983-05-02 1986-10-14 Peyman Gholam A Intraocular lenses with openable haptic loops
US4618229A (en) 1983-07-22 1986-10-21 Bausch & Lomb Incorporated Bifocal contact lens
US4551864A (en) 1983-08-18 1985-11-12 Iolab Corporation Anterior chamber lens
US4664666A (en) * 1983-08-30 1987-05-12 Ezekiel Nominees Pty. Ltd. Intraocular lens implants
DE3332313A1 (en) * 1983-09-07 1985-04-04 Titmus Eurocon Kontaktlinsen GmbH, 8750 Aschaffenburg MULTIFOCAL, ESPECIALLY BIFOCAL, INTRAOCULAR ARTIFICIAL EYE LENS
GB2146791B (en) 1983-09-16 1987-01-28 Suwa Seikosha Kk Progressive multifocal ophthalmic lens
US4636049A (en) * 1983-09-20 1987-01-13 University Optical Products Co. Concentric bifocal contact lens
US4562600A (en) * 1983-10-18 1986-01-07 Stephen P. Ginsberg Intraocular lens
US4560383A (en) 1983-10-27 1985-12-24 Leiske Larry G Anterior chamber intraocular lens
US4687484A (en) 1983-12-12 1987-08-18 Kaplan Linda J Anterior chamber intraocular lens
US4615701A (en) 1984-01-03 1986-10-07 Woods Randall L Intraocular lens and method of implantation thereof
US4596578A (en) 1984-01-30 1986-06-24 Kelman Charles D Intraocular lens with miniature optic
US4636211A (en) * 1984-03-13 1987-01-13 Nielsen J Mchenry Bifocal intra-ocular lens
US4629460A (en) 1984-06-25 1986-12-16 Dyer Robert L Intraocular lens
US4878911A (en) 1984-06-25 1989-11-07 Anis Aziz Y Flexible one-piece posterior chamber lens
US4720286A (en) * 1984-07-20 1988-01-19 Bailey Kelvin E Multifocus intraocular lens
US4693716A (en) * 1984-08-21 1987-09-15 Mackool Richard J Multipartite intraocular lens
US4976732A (en) 1984-09-12 1990-12-11 International Financial Associates Holdings, Inc. Optical lens for the human eye
FI79619C (en) 1984-12-31 1990-01-10 Antti Vannas Intraocular lens
US4581033A (en) * 1985-01-08 1986-04-08 Callahan Wayne B Unitary intraocular lens providing four-point support
US4725278A (en) * 1985-01-22 1988-02-16 Shearing Steven P Intraocular lens
US4759762A (en) 1985-03-08 1988-07-26 Grendahl Dennis T Accommodating lens
US4693572A (en) 1985-06-03 1987-09-15 Fused Kontacts Of Chicago, Inc. Monocentric bifocal corneal contact lens
US4661108A (en) * 1985-07-03 1987-04-28 Surgidev Corporation Intraocular lens
US4787903A (en) 1985-07-24 1988-11-29 Grendahl Dennis T Intraocular lens
US4731078A (en) * 1985-08-21 1988-03-15 Kingston Technologies Limited Partnership Intraocular lens
US4737322A (en) * 1985-09-27 1988-04-12 Staar Surgical Company Intraocular lens structure with polyimide haptic portion and methods for fabrication
US4752123A (en) 1985-11-19 1988-06-21 University Optical Products Co. Concentric bifocal contact lens with two distance power regions
US4890912A (en) * 1986-01-24 1990-01-02 Rients Visser Trifocal eye-contact lens
GB2192291B (en) 1986-03-04 1990-08-22 Gupta Anil K Progressive power contact lens.
GB8606821D0 (en) * 1986-03-19 1986-04-23 Pa Consulting Services Corneal reprofiling
US4840627A (en) * 1986-04-08 1989-06-20 Michael Blumenthal Artificial eye lens and method of transplanting same
US4725277A (en) 1986-05-14 1988-02-16 Precision-Cosmet Co., Inc. Intraocular lens with tapered haptics
EP0248489A3 (en) 1986-06-02 1989-09-06 Gregory N. Miller Contact lens and method of making same
US5192318A (en) * 1986-06-05 1993-03-09 Schneider Richard T One-piece bifocal intraocular lens construction
WO1987007496A1 (en) 1986-06-05 1987-12-17 Precision-Cosmet Co., Inc. One-piece bifocal intraocular lens construction
CS263203B1 (en) * 1986-07-22 1989-04-14 Sulc Jiri Soft intraocular lenses
US4676792A (en) 1986-08-26 1987-06-30 Donald Praeger Method and artificial intraocular lens device for the phakic treatment of myopia
US4710194A (en) 1986-10-20 1987-12-01 Kelman Charles D Intraocular lens with optic of expandable hydrophilic material
NO160823C (en) * 1987-02-11 1989-06-07 Jens G Hetland DEVICE FOR INTRA-OCULAR ROOM LENS.
US4885105A (en) 1987-05-14 1989-12-05 The Clorox Company Films from PVA modified with nonhydrolyzable anionic comonomers
US4842601A (en) * 1987-05-18 1989-06-27 Smith S Gregory Accommodating intraocular lens and method of implanting and using same
US5201762A (en) * 1987-05-20 1993-04-13 Hauber Frederick A Intraocular archromatic lens
US4790847A (en) 1987-05-26 1988-12-13 Woods Randall L Intraocular lens implant having eye focusing capabilities
US5270744A (en) 1987-06-01 1993-12-14 Valdemar Portney Multifocal ophthalmic lens
US4898461A (en) * 1987-06-01 1990-02-06 Valdemar Portney Multifocal ophthalmic lens
US5166711A (en) 1987-06-01 1992-11-24 Valdemar Portney Multifocal ophthalmic lens
US5166712A (en) 1987-06-01 1992-11-24 Valdemar Portney Multifocal ophthalmic lens
US5225858A (en) 1987-06-01 1993-07-06 Valdemar Portney Multifocal ophthalmic lens
US4769035A (en) 1987-06-02 1988-09-06 Kelman Charles D Artificial lens and the method for implanting such lens
US4769033A (en) 1987-07-02 1988-09-06 Nordan Lee T Intraocular multifocal lens
US5019099A (en) 1987-07-02 1991-05-28 Nordan Lee T Intraocular multifocal lens method for correcting the aphakic eye
US4917681A (en) * 1987-08-24 1990-04-17 Nordan Lee T Intraocular multifocal lens
US4932968A (en) * 1987-07-07 1990-06-12 Caldwell Delmar R Intraocular prostheses
US4906246A (en) * 1987-08-24 1990-03-06 Grendahl Dennis T Cylindrically segmented zone of focus artificial hydrogel lens
US4919663A (en) * 1987-08-24 1990-04-24 Grendahl Dennis T Laminated zone of focus artificial hydrogel lens
US4921496A (en) 1987-08-24 1990-05-01 Grendahl Dennis T Radially segemented zone of focus artificial hydrogel lens
US4813481A (en) * 1987-08-27 1989-03-21 Otis Engineering Corporation Expendable flapper valve
US5158572A (en) 1987-09-10 1992-10-27 Nielsen James Mchenry Multifocal intraocular lens
US5047052A (en) 1987-11-06 1991-09-10 Seymour Dubroff Anterior chamber intraocular lens with four point fixation
US4881804A (en) 1987-11-12 1989-11-21 Cohen Allen L Multifocal phase plate with a pure refractive portion
US4888012A (en) * 1988-01-14 1989-12-19 Gerald Horn Intraocular lens assemblies
GB2215076A (en) 1988-02-02 1989-09-13 Dennis T Grendahl Intraocular lens having a hard optic and a soft skirt
US4888016A (en) 1988-02-10 1989-12-19 Langerman David W "Spare parts" for use in ophthalmic surgical procedures
IT1215851B (en) 1988-02-11 1990-02-22 Renato Liffredo INTRAOCULAR LENS WITH CHROMATIC CORRECTION AND ABSORPTION DIAGRAM.
DE68920167T2 (en) 1988-02-12 1995-06-29 Menicon Co Ltd Method of making an intraocular lens balloon.
US5000559A (en) * 1988-02-29 1991-03-19 Nikon Corporation Ophthalmic lenses having progressively variable refracting power
CA1316728C (en) 1988-04-01 1993-04-27 Michael J. Simpson Multi-focal diffractive ophthalmic lenses
CS271606B1 (en) 1988-04-11 1990-10-12 Sulc Jiri Intraocular optical system
US5089024A (en) * 1988-04-19 1992-02-18 Storz Instrument Company Multi-focal intraocular lens
FR2631228B1 (en) 1988-05-11 1990-08-10 Domilens Laboratoires INTRA-EYE IMPLANT OF PREVIOUS CHAMBER
US4932970A (en) 1988-05-17 1990-06-12 Allergan, Inc. Ophthalmic lens
IT1217703B (en) 1988-05-24 1990-03-30 Mario Giovanzana MULTIFOCAL CONTACT LENS WITH PROGRESSIVE ECCENTRICITY AND PROCEDURE FOR ITS MANUFACTURE
US4878910A (en) 1988-06-13 1989-11-07 Koziol Jeffrey E Intraocular lens assembly
US4923296A (en) 1988-07-14 1990-05-08 Erickson Paul M Oriented simultaneous vision bifocal contact lenses or the like utilizing introaocular suppression of blur
CN1020134C (en) 1988-07-20 1993-03-17 艾伦·L·科恩 Multifocal optical device
US5139519A (en) 1988-07-26 1992-08-18 Kalb Irvin M Multi-focal intra-ocular lens
US5192317A (en) * 1988-07-26 1993-03-09 Irvin Kalb Multi focal intra-ocular lens
US4830481A (en) 1988-08-12 1989-05-16 Minnesota Mining And Manufacturing Company Multifocal diffractive lens
US4932966A (en) 1988-08-15 1990-06-12 Storz Instrument Company Accommodating intraocular lens
US4994082A (en) * 1988-09-09 1991-02-19 Ophthalmic Ventures Limited Partnership Accommodating intraocular lens
US4990159A (en) * 1988-12-02 1991-02-05 Kraff Manus C Intraocular lens apparatus with haptics of varying cross-sectional areas
US4892543A (en) * 1989-02-02 1990-01-09 Turley Dana F Intraocular lens providing accomodation
FR2642854B1 (en) 1989-02-03 1991-05-03 Essilor Int OPTICAL LENS WITH SIMULTANEOUS VISION FOR PRESBYTIA CORRECTION
US4946469A (en) * 1989-04-20 1990-08-07 Faezeh Sarfarazi Intraocular lens
FR2647227B1 (en) 1989-05-19 1991-08-23 Essilor Int OPTICAL COMPONENT, SUCH AS AN INTRAOCULAR IMPLANT OR CONTACT LENS, SUITABLE FOR CORRECTING THE VISION OF AN INDIVIDUAL
US4955902A (en) 1989-11-13 1990-09-11 Kelman Charles D Decentered intraocular lens
US5002382A (en) * 1989-12-07 1991-03-26 Leonard Seidner Multifocal corneal contact lenses
WO1995003783A1 (en) 1990-03-06 1995-02-09 Houston Biotechnology Incorporated Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
US5476514A (en) * 1990-04-27 1995-12-19 Cumming; J. Stuart Accommodating intraocular lens
US6197059B1 (en) * 1990-04-27 2001-03-06 Medevec Licensing, B.V. Accomodating intraocular lens
US5047051A (en) * 1990-04-27 1991-09-10 Cumming J Stuart Intraocular lens with haptic anchor plate
US5096285A (en) * 1990-05-14 1992-03-17 Iolab Corporation Multifocal multizone diffractive ophthalmic lenses
US5147397A (en) 1990-07-03 1992-09-15 Allergan, Inc. Intraocular lens and method for making same
US5171266A (en) 1990-09-04 1992-12-15 Wiley Robert G Variable power intraocular lens with astigmatism correction
US5173723A (en) 1990-10-02 1992-12-22 Volk Donald A Aspheric ophthalmic accommodating lens design for intraocular lens and contact lens
US5112351A (en) 1990-10-12 1992-05-12 Ioptex Research Inc. Multifocal intraocular lenses
US5260727A (en) 1990-10-22 1993-11-09 Oksman Henry C Wide depth of focus intraocular and contact lenses
US5258025A (en) 1990-11-21 1993-11-02 Fedorov Svjatoslav N Corrective intraocular lens
DE4038088C2 (en) 1990-11-29 1994-05-19 Klaas Dieter Artificial eye lens implant
CH681687A5 (en) 1991-03-07 1993-05-14 Helmut Dr Med Payer Artificial lens for human eye - comprises elastically deformable lens body surrounded by elastically deformable force transmission part
EP0507292B1 (en) 1991-04-04 1997-07-02 Menicon Co., Ltd. Device for inhibiting aftercataract
US5152789A (en) 1991-05-14 1992-10-06 Allergan, Inc. Fixation member for an intraocular lens
US5766244A (en) 1991-05-23 1998-06-16 Binder; Helmut Intraocular artificial lens and method for fabricating same
US5326347A (en) 1991-08-12 1994-07-05 Cumming J Stuart Intraocular implants
EP0601055B1 (en) 1991-08-16 2000-06-07 GALIN, Miles A. Medicament coated refractive anterior chamber ocular implant
FR2681524B1 (en) 1991-09-25 1997-04-04 Mnao CRYSTALLINE IMPLANT.
US5578081A (en) 1991-11-12 1996-11-26 Henry H. McDonald Eye muscle responsive artificial lens unit
US5275623A (en) * 1991-11-18 1994-01-04 Faezeh Sarfarazi Elliptical accommodative intraocular lens for small incision surgery
NL9200400A (en) 1992-03-04 1993-10-01 Jose Jorge Pavlotzky Handelend BIFOCAL CONTACT LENS, AND METHOD FOR MANUFACTURING SUCH CONTACT LENSES
US5443506A (en) * 1992-11-18 1995-08-22 Garabet; Antoine L. Lens with variable optical properties
NZ250359A (en) 1992-12-09 1996-07-26 Johnson & Johnson Vision Prod Multifocal ophthalmic lens pair
US5375611A (en) 1993-01-26 1994-12-27 Pharmacia Ab Method for preventing secondary cataract
US5354335A (en) 1993-02-04 1994-10-11 Isaac Lipshitz Intraocular insert for implantation in the human eye
US6322589B1 (en) 1995-10-06 2001-11-27 J. Stuart Cumming Intraocular lenses with fixated haptics
RU2033114C1 (en) * 1993-04-22 1995-04-20 Межотраслевой научно-технический комплекс "Микрохирургия глаза" Artificial crystalline lens
US5366501A (en) * 1993-05-12 1994-11-22 Langerman David W Intraocular lens with dual 360 degree haptics
DE4403326C1 (en) 1994-02-03 1995-06-22 Hans Reinhard Prof Dr Koch Intraocular lens arrangement for astigmatism correction
WO1995028897A2 (en) * 1994-04-19 1995-11-02 Mcdonald Henry H Lens insertable between the iris and the natural lens
US5489302A (en) * 1994-05-24 1996-02-06 Skottun; Bernt C. Accommodating intraocular lens
JP3745394B2 (en) 1994-07-04 2006-02-15 武敏 鈴木 Intraocular lens
WO1996010968A1 (en) 1994-10-06 1996-04-18 Vladimir Feingold Intraocular contact lens and method of implantation
US6013101A (en) * 1994-11-21 2000-01-11 Acuity (Israel) Limited Accommodating intraocular lens implant
IL111713A (en) 1994-11-21 2002-02-10 Israel Henry M Intraocular lens assembly
US5574518A (en) 1995-01-10 1996-11-12 Les Laboratoires Opti-Centre Inc. System incorporation two different sphero-non-spherical contact lenses for correcting presbytia
DE19501444A1 (en) 1995-01-19 1996-07-25 Morcher Gmbh Intra ocular two lens system
ATE272990T1 (en) 1995-02-15 2004-08-15 Medevec Licensing Bv ADJUSTABLE INTRAOCULAR LENS WITH T-SHAPED BRACKETS
US5628795A (en) 1995-03-15 1997-05-13 Langerman David W Spare parts for use in ophthalmic surgical procedures
HUP9601126A3 (en) 1995-05-04 1999-10-28 Johnson & Johnson Vision Prod Concentric, aspheric, multifocal lens
US5682223A (en) 1995-05-04 1997-10-28 Johnson & Johnson Vision Products, Inc. Multifocal lens designs with intermediate optical powers
US5684560A (en) 1995-05-04 1997-11-04 Johnson & Johnson Vision Products, Inc. Concentric ring single vision lens designs
US5652638A (en) 1995-05-04 1997-07-29 Johnson & Johnson Vision Products, Inc. Concentric annular ring lens designs for astigmatism
US5607472A (en) * 1995-05-09 1997-03-04 Emory University Intraocular lens for restoring accommodation and allows adjustment of optical power
US5774274A (en) * 1995-05-12 1998-06-30 Schachar; Ronald A. Variable focus lens by small changes of the equatorial lens diameter
US5800530A (en) 1995-08-18 1998-09-01 Rizzo, Iii; Joseph Intra-ocular lens system including microelectric components
US5968094A (en) 1995-09-18 1999-10-19 Emmetropia, Inc. Compound intraocular lens
BR9610704A (en) 1995-09-29 1999-12-21 Polyvue Bahamas Ltd Contact lens, intraocular implant, refractive surgical procedure and process to align a central region of a contact lens.
WO1997012564A1 (en) * 1995-10-06 1997-04-10 Cumming J Stuart Intraocular lenses with fixated haptics
US5984962A (en) 1996-01-22 1999-11-16 Quantum Vision, Inc. Adjustable intraocular lens
IT1282072B1 (en) 1996-02-02 1998-03-09 Soleko S P A INTRAOCULAR LENS
FR2744908B1 (en) 1996-02-20 1998-06-12 W K Et Associes MYOPIC INTRAOCULAR IMPLANT
US5628797A (en) 1996-02-23 1997-05-13 Richer; Homer E. Cosmetic anterior chamber, intraocular lens and implantation method
EP0901354B1 (en) 1996-05-17 2004-03-17 Helmut Payer An ocular implant
US6503275B1 (en) * 1996-11-15 2003-01-07 Medevec Licensing, B.V. Ophthalmic lens insertion instrument and package
US5769890B1 (en) 1997-01-16 2000-09-05 Surgical Concepts Inc Placement of second artificial lens in eye to correct for optical defects of first artificial lens in eye
US5898473A (en) * 1997-04-25 1999-04-27 Permeable Technologies, Inc. Multifocal corneal contact lens
US5928282A (en) 1997-06-13 1999-07-27 Bausch & Lomb Surgical, Inc. Intraocular lens
US5928283A (en) 1997-06-26 1999-07-27 Visioncare Ltd Telescopic device for an intraocular lens
IL121417A0 (en) 1997-07-28 1998-01-04 Israel Henry M Intraocular ring
US5843188A (en) 1997-10-20 1998-12-01 Henry H. McDonald Accommodative lens implantation
US5876442A (en) * 1998-01-15 1999-03-02 Visioncare Ltd. Intraocular lens implant with telescope support
US5814103A (en) 1998-01-15 1998-09-29 Visioncare Ltd. Intraocular lens and telescope with mating fasteners
US6083261A (en) * 1998-05-28 2000-07-04 Callahan; Wayne B. Crossed haptics for intraocular lenses
SE9803481D0 (en) * 1998-10-13 1998-10-13 Pharmacia & Upjohn Ab Photocurable siloxane polymers
US6231603B1 (en) 1998-11-10 2001-05-15 Allergan Sales, Inc. Accommodating multifocal intraocular lens
US6152958A (en) 1998-12-16 2000-11-28 Nordan; Lee T. Foldable thin intraocular membrane
US6176878B1 (en) * 1998-12-17 2001-01-23 Allergan Sales, Inc. Accommodating intraocular lens
US6117171A (en) 1998-12-23 2000-09-12 Skottun; Bernt Christian Encapsulated accommodating intraocular lens
US6197058B1 (en) * 1999-03-22 2001-03-06 Valdemar Portney Corrective intraocular lens system and intraocular lenses and lens handling device therefor
US7662179B2 (en) * 1999-04-09 2010-02-16 Sarfarazi Faezeh M Haptics for accommodative intraocular lens system
US6488708B2 (en) * 1999-04-09 2002-12-03 Faezeh Sarfarazi Open chamber, elliptical, accommodative intraocular lens system
US20030060881A1 (en) * 1999-04-30 2003-03-27 Advanced Medical Optics, Inc. Intraocular lens combinations
US20060238702A1 (en) 1999-04-30 2006-10-26 Advanced Medical Optics, Inc. Ophthalmic lens combinations
US6790232B1 (en) 1999-04-30 2004-09-14 Advanced Medical Optics, Inc. Multifocal phakic intraocular lens
US6616692B1 (en) 1999-04-30 2003-09-09 Advanced Medical Optics, Inc. Intraocular lens combinations
US6406494B1 (en) 1999-04-30 2002-06-18 Allergan Sales, Inc. Moveable intraocular lens
US6200342B1 (en) * 1999-05-11 2001-03-13 Marie-Jose B. Tassignon Intraocular lens with accommodative properties
US6599317B1 (en) * 1999-09-17 2003-07-29 Advanced Medical Optics, Inc. Intraocular lens with a translational zone
FR2799952B1 (en) 1999-10-21 2001-12-14 Humanoptics Ag INTRAOCULAR IMPLANT
US6767363B1 (en) 1999-11-05 2004-07-27 Bausch & Lomb Surgical, Inc. Accommodating positive and negative intraocular lens system
FR2800596B1 (en) 1999-11-10 2002-03-22 Ioltechnologie Production PRECRYSTALLINE INTRAOCULAR IMPLANT
DE50013494D1 (en) 1999-12-14 2006-11-02 Boehm Hans Georg Focusable intraocular lens
DE19961603A1 (en) * 1999-12-21 2001-06-28 Bayer Ag Production of 2-chlorocyclopropyl-1-chlorophenyl-triazolonyl-propanol derivative, useful as microbicide, from 2-chlorocyclopropyl-2-chlorobenzyl-oxirane
WO2001056508A1 (en) * 2000-02-03 2001-08-09 Accommo Ag Lens implant
US20050085907A1 (en) * 2000-02-16 2005-04-21 Humanoptics Ag Intraocular implant and an artificial lens device
FR2804860B1 (en) * 2000-02-16 2002-04-12 Humanoptics Ag ACCOMODATIVE CRYSTALLINE IMPLANT
US6551354B1 (en) * 2000-03-09 2003-04-22 Advanced Medical Optics, Inc. Accommodating intraocular lens
US6554859B1 (en) * 2000-05-03 2003-04-29 Advanced Medical Optics, Inc. Accommodating, reduced ADD power multifocal intraocular lenses
US6660035B1 (en) 2000-08-02 2003-12-09 Advanced Medical Optics, Inc. Accommodating intraocular lens with suspension structure
US20060116765A1 (en) * 2000-08-04 2006-06-01 Blake Larry W Refractive corrective lens (RCL)
AU2001288926A1 (en) 2000-09-07 2002-03-22 Allergan Sales, Inc. Intraocular lens with a posterior lens portion
US6666887B1 (en) 2000-10-20 2003-12-23 Thinoptx, Inc. Deformable intraocular multi-focus lens
US6592621B1 (en) * 2000-11-10 2003-07-15 Rudolph S. Domino Flexible intra-ocular lens of variable focus
US6558420B2 (en) * 2000-12-12 2003-05-06 Bausch & Lomb Incorporated Durable flexible attachment components for accommodating intraocular lens
US6786934B2 (en) * 2001-01-25 2004-09-07 Visiogen, Inc. Biasing element for intraocular lens system
US6884261B2 (en) * 2001-01-25 2005-04-26 Visiogen, Inc. Method of preparing an intraocular lens for implantation
US20020120329A1 (en) 2001-02-28 2002-08-29 Allergan Sales, Inc. Moveable intraocular lenses and combinations of intraocular lenses
US6638305B2 (en) 2001-05-15 2003-10-28 Advanced Medical Optics, Inc. Monofocal intraocular lens convertible to multifocal intraocular lens
US6524340B2 (en) * 2001-05-23 2003-02-25 Henry M. Israel Accommodating intraocular lens assembly
US6855164B2 (en) * 2001-06-11 2005-02-15 Vision Solutions Technologies, Llc Multi-focal intraocular lens, and methods for making and using same
DE60231717D1 (en) * 2001-08-10 2009-05-07 Basf Plant Science Gmbh SUGAR AND LIPID METABOLISM REGULATORS IN PLANTS III
DE10139027A1 (en) 2001-08-15 2003-02-27 Humanoptics Ag Intraocular implant
IL145015A0 (en) * 2001-08-21 2002-06-30 Nun Yehoshua Ben Accommodating lens
US6443985B1 (en) * 2001-08-27 2002-09-03 Randall Woods Intraocular lens implant having eye accommodating capabilities
US20030060878A1 (en) * 2001-08-31 2003-03-27 Shadduck John H. Intraocular lens system and method for power adjustment
US7097660B2 (en) * 2001-12-10 2006-08-29 Valdemar Portney Accommodating intraocular lens
US7025783B2 (en) * 2002-01-14 2006-04-11 Advanced Medical Optics, Inc. Accommodating intraocular lens with integral capsular bag ring
US7150759B2 (en) 2002-01-14 2006-12-19 Advanced Medical Optics, Inc. Multi-mechanistic accommodating intraocular lenses
FR2835424B1 (en) * 2002-02-01 2004-11-26 Khalil Hanna ACCOMODATIVE INTRACAPSULAR IMPLANT
US8048155B2 (en) * 2002-02-02 2011-11-01 Powervision, Inc. Intraocular implant devices
US20050021139A1 (en) * 2003-02-03 2005-01-27 Shadduck John H. Ophthalmic devices, methods of use and methods of fabrication
US6935743B2 (en) 2002-02-06 2005-08-30 John H. Shadduck Adaptive optic lens and method of making
US20030171809A1 (en) * 2002-03-05 2003-09-11 Phillips Andrew F. Axial-displacement accommodating intraocular lens
US7179292B2 (en) * 2002-03-15 2007-02-20 Ophtec B.V. Intraocular lens for implantation in an eye and instrument and methods for insertion of such a lens
US20030187505A1 (en) 2002-03-29 2003-10-02 Xiugao Liao Accommodating intraocular lens with textured haptics
US20040158322A1 (en) * 2002-04-17 2004-08-12 Shen Jin Hui Intraocular lens system
US6695881B2 (en) 2002-04-29 2004-02-24 Alcon, Inc. Accommodative intraocular lens
US7018409B2 (en) * 2002-09-13 2006-03-28 Advanced Medical Optics, Inc. Accommodating intraocular lens assembly with aspheric optic design
US20040082993A1 (en) 2002-10-25 2004-04-29 Randall Woods Capsular intraocular lens implant having a refractive liquid therein
US7125422B2 (en) * 2002-10-25 2006-10-24 Quest Vision Technology, Inc. Accommodating intraocular lens implant
US20040082995A1 (en) * 2002-10-25 2004-04-29 Randall Woods Telescopic intraocular lens implant for treating age-related macular degeneration
US7217288B2 (en) 2002-12-12 2007-05-15 Powervision, Inc. Accommodating intraocular lens having peripherally actuated deflectable surface and method
US6616691B1 (en) 2003-01-10 2003-09-09 Alcon, Inc. Accommodative intraocular lens
US20040167621A1 (en) * 2003-02-26 2004-08-26 Peyman Gholam A. Teledioptic lens system and method for using the same
US7223288B2 (en) * 2003-05-21 2007-05-29 Alcon, Inc. Accommodative intraocular lens
EP1501099B1 (en) * 2003-07-23 2008-01-23 EM Microelectronic-Marin SA Non volatile memory array with split gate cells and method for avoiding disturbance when programming
US20050027354A1 (en) * 2003-07-28 2005-02-03 Advanced Medical Optics, Inc. Primary and supplemental intraocular lens
US20050038510A1 (en) 2003-08-13 2005-02-17 Valdemar Portney Multi-piece intraocular lens assembly and method of manufacturing same
GB0319408D0 (en) 2003-08-19 2003-09-17 Chawdhary Satish Intraocular device
US7553327B2 (en) * 2003-12-04 2009-06-30 The Nice Trust, A Trust Of The Isle Of Man Accommodating 360 degree sharp edge optic plate haptic lens
US20050137703A1 (en) * 2003-12-05 2005-06-23 Vanderbilt University Accommodative intraocular lens
US20050131535A1 (en) 2003-12-15 2005-06-16 Randall Woods Intraocular lens implant having posterior bendable optic
US7632864B2 (en) * 2004-03-17 2009-12-15 Hikal Ltd. Gabapentin analogues and process thereof
DE102004025305A1 (en) 2004-05-19 2005-12-08 Humanoptics Ag Accommodatable intraocular lens
US20070135915A1 (en) * 2004-09-17 2007-06-14 Klima William L Implantable lens device
US20060064162A1 (en) * 2004-09-17 2006-03-23 Klima William L 333Intraocular lens device
US7815678B2 (en) 2004-10-13 2010-10-19 Nulens Ltd. Accommodating intraocular lens (AIOL), and AIOL assemblies including same
US9636213B2 (en) * 2005-09-30 2017-05-02 Abbott Medical Optics Inc. Deformable intraocular lenses and lens systems
US8241355B2 (en) * 2005-10-28 2012-08-14 Abbott Medical Optics Inc. Haptic for accommodating intraocular lens
US20070129803A1 (en) 2005-12-06 2007-06-07 C&C Vision International Limited Accommodative Intraocular Lens
US20070260309A1 (en) 2006-05-08 2007-11-08 Richardson Gary A Accommodating intraocular lens having a recessed anterior optic
US7713299B2 (en) * 2006-12-29 2010-05-11 Abbott Medical Optics Inc. Haptic for accommodating intraocular lens
CA2674018C (en) * 2006-12-29 2015-05-26 Advanced Medical Optics, Inc. Multifocal accommodating intraocular lens
US20080161914A1 (en) * 2006-12-29 2008-07-03 Advanced Medical Optics, Inc. Pre-stressed haptic for accommodating intraocular lens
US8608799B2 (en) * 2007-01-24 2013-12-17 Tekia, Inc. Umbrella-shaped accommodating artificial ocular lens (AAOL) device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217612B1 (en) * 1999-09-10 2001-04-17 Randall Woods Intraocular lens implant having eye accommodating capabilities
US6299641B1 (en) * 1999-09-10 2001-10-09 Randall Woods Intraocular lens implant having eye accommodating capabilities
US6645246B1 (en) * 1999-09-17 2003-11-11 Advanced Medical Optics, Inc. Intraocular lens with surrounded lens zone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1562521A2 *

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9814570B2 (en) 1999-04-30 2017-11-14 Abbott Medical Optics Inc. Ophthalmic lens combinations
US9504560B2 (en) 2002-01-14 2016-11-29 Abbott Medical Optics Inc. Accommodating intraocular lens with outer support structure
US9271830B2 (en) 2002-12-05 2016-03-01 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US10206773B2 (en) 2002-12-05 2019-02-19 Johnson & Johnson Surgical Vision, Inc. Accommodating intraocular lens and method of manufacture thereof
US9198752B2 (en) 2003-12-15 2015-12-01 Abbott Medical Optics Inc. Intraocular lens implant having posterior bendable optic
US10912643B2 (en) 2004-04-29 2021-02-09 Forsight Vision6, Inc. Accommodating intraocular lens assemblies and accommodation measurement implant
US10166096B2 (en) 2005-03-30 2019-01-01 Forsight Vision6, Inc. Foldable accommodating intraocular lens
US9814568B2 (en) 2005-03-30 2017-11-14 Forsight Vision6, Inc. Accommodating intraocular lens having dual shape memory optical elements
US10966818B2 (en) 2005-03-30 2021-04-06 Forsight Vision6, Inc. Accommodating intraocular lens (AIOL) assemblies, and discrete components therefor
US9636213B2 (en) 2005-09-30 2017-05-02 Abbott Medical Optics Inc. Deformable intraocular lenses and lens systems
US9084662B2 (en) 2006-01-17 2015-07-21 Transcend Medical, Inc. Drug delivery treatment device
US9668917B2 (en) 2006-01-17 2017-06-06 Novartis Ag Drug delivery treatment device
US9039760B2 (en) 2006-12-29 2015-05-26 Abbott Medical Optics Inc. Pre-stressed haptic for accommodating intraocular lens
US11376116B2 (en) 2007-08-13 2022-07-05 Ocumetics Technology Corp. Inflatable intra ocular lens/lens retainer
US9107748B2 (en) 2007-12-27 2015-08-18 Forsight Labs, Llc Intraocular, accommodating lens and methods of use
US8414646B2 (en) 2007-12-27 2013-04-09 Forsight Labs, Llc Intraocular, accommodating lens and methods of use
US8715346B2 (en) 2007-12-27 2014-05-06 Forsight Labs, Llc Intraocular, accommodating lens and methods of use
US8167941B2 (en) 2008-01-03 2012-05-01 Forsight Labs, Llc Intraocular, accommodating lens and methods of use
US9050765B2 (en) 2008-01-03 2015-06-09 Forsight Labs, Llc Intraocular, accommodating lens and methods of use
US9968441B2 (en) 2008-03-28 2018-05-15 Johnson & Johnson Surgical Vision, Inc. Intraocular lens having a haptic that includes a cap
US10052194B2 (en) 2009-06-26 2018-08-21 Johnson & Johnson Surgical Vision, Inc. Accommodating intraocular lenses
US9011532B2 (en) 2009-06-26 2015-04-21 Abbott Medical Optics Inc. Accommodating intraocular lenses
US10105215B2 (en) 2009-08-03 2018-10-23 Johnson & Johnson Surgical Vision, Inc. Intraocular lens and methods for providing accommodative vision
US9603703B2 (en) 2009-08-03 2017-03-28 Abbott Medical Optics Inc. Intraocular lens and methods for providing accommodative vision
US10772721B2 (en) 2010-04-27 2020-09-15 Lensgen, Inc. Accommodating intraocular lens
US11918458B2 (en) 2011-02-04 2024-03-05 Forsight Vision6, Inc. Intraocular accommodating lens and methods of use
US11076947B2 (en) 2011-02-04 2021-08-03 Forsight Vision6, Inc. Intraocular accommodating lens and methods of use
US10639141B2 (en) 2011-02-04 2020-05-05 Forsight Vision6, Inc. Intraocular accommodating lens and methods of use
US9913712B2 (en) 2011-02-04 2018-03-13 Forsight Labs, Llc Intraocular accommodating lens and methods of use
US9987125B2 (en) 2012-05-02 2018-06-05 Johnson & Johnson Surgical Vision, Inc. Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
EP2906146B1 (en) * 2012-12-17 2022-04-27 Alcon Inc. Capsule expander device
US10842616B2 (en) 2013-11-01 2020-11-24 Lensgen, Inc. Accommodating intraocular lens device
US11000364B2 (en) 2013-11-01 2021-05-11 Lensgen, Inc. Two-part accommodating intraocular lens device
US10159564B2 (en) 2013-11-01 2018-12-25 Lensgen, Inc. Two-part accomodating intraocular lens device
US11464624B2 (en) 2013-11-01 2022-10-11 Lensgen, Inc. Two-part accommodating intraocular lens device
US11464622B2 (en) 2013-11-01 2022-10-11 Lensgen, Inc. Two-part accommodating intraocular lens device
US11471273B2 (en) 2013-11-01 2022-10-18 Lensgen, Inc. Two-part accommodating intraocular lens device
US11331182B2 (en) 2014-03-28 2022-05-17 Forsight Vision6, Inc. Accommodating intraocular lens
US10285805B2 (en) 2014-03-28 2019-05-14 Forsight Labs, Llc Accommodating intraocular lens
US11826246B2 (en) 2014-07-31 2023-11-28 Lensgen, Inc Accommodating intraocular lens device
US10485654B2 (en) 2014-07-31 2019-11-26 Lensgen, Inc. Accommodating intraocular lens device
US11464621B2 (en) 2014-07-31 2022-10-11 Lensgen, Inc. Accommodating intraocular lens device
US10647831B2 (en) 2014-09-23 2020-05-12 LensGens, Inc. Polymeric material for accommodating intraocular lenses
US11471270B2 (en) 2015-12-01 2022-10-18 Lensgen, Inc. Accommodating intraocular lens device
US11065107B2 (en) 2015-12-01 2021-07-20 Lensgen, Inc. Accommodating intraocular lens device
US10526353B2 (en) 2016-05-27 2020-01-07 Lensgen, Inc. Lens oil having a narrow molecular weight distribution for intraocular lens devices
US11523898B2 (en) 2016-10-28 2022-12-13 Forsight Vision6, Inc. Accommodating intraocular lens and methods of implantation
US11707354B2 (en) 2017-09-11 2023-07-25 Amo Groningen B.V. Methods and apparatuses to increase intraocular lenses positional stability

Also Published As

Publication number Publication date
WO2004037127A3 (en) 2004-06-10
EP1562521A2 (en) 2005-08-17
US20040082993A1 (en) 2004-04-29
CA2503961A1 (en) 2004-05-06
EP2295009B1 (en) 2013-07-03
EP2295009A1 (en) 2011-03-16
US8545556B2 (en) 2013-10-01
CA2503961C (en) 2012-04-24
US20040111153A1 (en) 2004-06-10
EP1562521A4 (en) 2006-09-20
DE60330492D1 (en) 2010-01-21
EP2161003A1 (en) 2010-03-10
US8585758B2 (en) 2013-11-19
EP1562521B1 (en) 2009-12-09
CA2768127C (en) 2015-01-06
US20120046744A1 (en) 2012-02-23
US20110035001A1 (en) 2011-02-10
CA2768127A1 (en) 2004-05-06
ATE451079T1 (en) 2009-12-15
US20060212116A1 (en) 2006-09-21
US8052752B2 (en) 2011-11-08

Similar Documents

Publication Publication Date Title
US8545556B2 (en) Capsular intraocular lens implant
US10772721B2 (en) Accommodating intraocular lens
AU2004299063B2 (en) Intraocular lens implant having posterior bendable optic
AU2003286723B2 (en) Accomodating intraocular lens implant
US6443985B1 (en) Intraocular lens implant having eye accommodating capabilities
AU2003243726B2 (en) Elliptical accommodative intraocular lens
AU2002317586A1 (en) Intraocular lens implant having eye accommodating capabilities
JP4473217B2 (en) Implantable artificial lens
AU2003301524B8 (en) Capsular intraocular lens implant having a refractive material therein
AU2011218619B2 (en) Intraocular lens implant having posterior bendable optic

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005501704

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2503961

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003301524

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003809651

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003809651

Country of ref document: EP